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ABSTRACT
DESIGNING AND SAMPLE SIZE CALCULATION IN PRESENCE OF
HETEROGENEITY IN BIOLOGICAL STUDIES INVOLVING
HIGH-THROUGHPUT DATA
Sudhir Srivastava
July 17, 2019
The designing and determination of sample size are important for conducting
high-throughput biological experiments such as proteomics experiments and
RNA-Seq expression studies, thus leading to better understanding of complex
mechanisms underlying various biological processes. The variations in the
biological data or technical approaches to data collection lead to heterogeneity
for the samples under study. We critically worked on the issues of technical and
biological heterogeneity.
The quantitative measurements based on liquid chromatography (LC)
coupled with mass spectrometry (MS) often suffer from the problem of missing
values (MVs) and data heterogeneity. We considered a proteomics data set
generated from human kidney biopsy material to investigate the technical effects
of sample preparation and the quantitative MS. We studied the effect of tissue
storage methods (TSMs) and tissue extraction methods (TEMs) on data analysis.
There are two TSMs: frozen (FR) and FFPE (formalin-fixed paraffin embedded);
and three TEMs: MAX, TX followed by MAX and SDS followed by MAX. We
vi

assessed the impact of different strategies to analyze the data while considering
heterogeneity and MVs. We found that the FFPE is better than that of FR for
tissue storage. We also found that the one-step TEM (MAX) is better than those
of two-steps TEMs. Furthermore, we found the imputation method is a better
approach than excluding the proteins with MVs or using unbalanced design.
We

introduce

a

web

application,

PWST

(Proteomics

Workflow

Standardization Tool) to standardize the proteomics workflow. The tool will be
helpful in deciding the most suitable choice for each step and studying the
variability associated with technical steps as well as the effects of continuous
variables. We have used the special cases of general linear model - ANCOVA
and ANOVA with fixed effects to study the effects due to various sources of
variability. We introduce an interactive tool, “SATP: Statistical Analysis Tool for
Proteomics”, for analyzing proteomics expression data that is scalable to large
clinical proteomic studies. The user can perform differential expression analysis
of proteomics data either at the protein or peptide level using multiple
approaches. We have developed statistical approaches for calculating sample
size for proteomics experiments under allocation and cost constraints. We have
developed R programs and a shiny app “SSCP: Sample Size Calculator for
Proteomics Experiment” for computing sample sizes.
We have proposed statistical approaches for calculating sample size for
RNA-Seq experiments considering allocation and cost. We have developed R
programs and shiny apps to calculate sample size for conducting RNA-Seq
experiments.
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CHAPTER 1
INTRODUCTION

Design and sample size calculation for high-throughput experiments
The designing and determination of sample size are important for conducting
high-throughput biological experiments such as proteomics experiments and
RNA-Seq expression studies, thus leading to better understanding of complex
mechanisms underlying various biological processes. These experiments
undergo various steps such as choosing appropriate experimental design, proper
selection and collection of samples from various sources, choice of platform, data
generation, data preprocessing, data analysis and interpretation. Various
experiments are being conducted but there is lot of variation at each of these
steps. There are various discrepancies observed with the result and conclusions
obtained from these experiments. Sometimes these results cannot be
reproduced, and this failure may be derived from one or more technical variables.
So, we studied the data variability and developed statistical approaches for
sample size determination for these experiments while taking various
heterogeneity issues in account.
This research work has focused on the development of statistical methods
for designing and sample size calculation covering a wide range of high
throughput

biological

experiments

such

1

as

proteomics

and

RNA-Seq

experiments. This is an innovative work that will be helpful to researchers/
experimenters in the design of their study applicable to different areas such as
proteomics and genomics. This will bring out clarity to the experimenters in
conducting their study with a specific goal.

Contributions
Identification, quantification and characterization of peptides and proteins in cells,
are necessary to understand the molecular process governing the cell
physiology. Liquid chromatography (LC) coupled with mass spectrometry (MS) is
generally used for identifying and quantifying proteins and peptides in complex
mixtures. With the introduction of high throughput technologies such as MS,
proteomics data can be reliably generated from samples that can be further
analyzed using various statistical approaches. Sometimes, variations in the
biological data or technical approaches to data collection lead to heterogeneity
for the samples under study. Furthermore, the proteomics data obtained from
proteomics experiments have a lot of missing values (MVs) and are highly
heterogeneous. We investigated the technical effects of sample preparation and
the quantitative MS resulting in heterogeneity for low abundant protein
quantification (Chapter 3). We developed statistical approaches and a webapplication for standardizing proteomics experiment work flow (Chapters 3 and
4). We discussed and developed a shiny app for differential expression analysis
of proteomics data using multiple statistical approaches in the presence of
heterogeneity and MVs (Chapter 5). We devised various approaches for sample
size calculation for conducting proteomics experiments under allocation and
2

budget constraints (Chapter 6). Furthermore, we developed shiny apps for
estimating sample size for proteomics studies based on different constraints with
and without using pilot data (Chapter 6). We studied the impact of technical
variability (using data from Chapter 3) on the study design and sample size
estimation in Chapter 6.
Next-generation sequencing (NGS) of mRNA (RNA-Seq) has become the
standard for measuring gene expressions in biological experiments. The
determination of sequencing depth, number of replicates and power calculation
are important while designing an RNA-Seq experiment. Various methods exist for
estimating sample size for differential expression analysis of RNA-Seq data
under the assumption of different models. The RNA-seq experiments are
complex in nature, and still there is requirement of advanced method to calculate
sample size for differential expression analysis using RNA-Seq data. Therefore,
we devised statistical approaches for designing and sample size calculation
considering allocation and cost constraints required to carry out the RNA-Seq
experiments under the assumptions of various models (Chapter 7).
We have implemented all the methods in R [1] and used various
Bioconductor packages [2], applicable to these experiments. We have developed
all the apps using “shiny” R package [3]. It will be easier for the experimenters to
calculate the sample size required for conducting the experiments according to
the budget. These programs can be used by the researchers for writing grants
and conducting research projects, that will save resources in terms of cost and
time.

3

Layout of the dissertation
The layout of the dissertation is as follows:
Chapter 2 provides the basic background of various topics such as sample size
calculation, heterogeneity issues, proteomics and RNA-Seq experiments.
Chapter 3 provides the technical and statistical considerations for standardizing
proteomics workflow for LC-MS proteomics expression data [4].
Chapter 4 provides the interactive web tool for standardizing proteomics workflow
for LC-MS Data [5].
Chapter 5 provides the various approaches for differential expression analysis of
proteomics expression data and an interactive tool for statistical analysis of labelfree LC-MS proteomics data considering MVs and heterogeneity.
Chapter 6 provides the sample size estimation methods for proteomics
experiments under various constraints.
Chapter 7 provides the statistical methods of sample size calculation for RNASeq experiments considering allocation and cost.
Chapter 8 provides the discussion and conclusion.

4

CHAPTER 2
PRELIMINARIES: SAMPLE SIZE CALCULATION, EXPERIMENTAL DESIGN
AND BIOLOGICAL EXPERIMENTS

Sample size calculation
Sample size calculation is an important process of choosing the number of
replicates in a study with the goal to make inferences about a population from a
sample. The sample size used in a study depends on various constraints such as
data availability, budget, support facilities, time requirement, etc. The basic
principles underlying the method of sample size calculation are the same, but
these methods are not universal. So, the methods of sample size calculation
depend on the type of experiment. In complicated studies, there may be several
different sample sizes involved. For example, in an experiment where a study
may be divided into different treatment groups/ conditions, there may be different
sample sizes for each group/ condition.
Methods for sample size calculations begin with an understanding of the
type of data and its distribution. In most of the experiments, the data can be
broadly divided into quantitative (numerical) and categorical (qualitative) data. Let
us consider there are two groups for comparison. Let the number of samples in
each group are 𝑁1 and 𝑁2 , respectively. In general, the following factors must be
known or estimated to calculate sample size [6-8]:

5

(i) The desired fold change: It is the difference between mean responses in the
two groups, i.e., the difference between 𝜇1 and 𝜇2 for quantitative data.
(ii) The population standard deviations (SDs): It is the variability or spread
associated with quantitative data. We require either common population SD (𝜎)
for the two groups or SDs (𝜎1 and 𝜎2 ) for each group. The population SD of the
variable of interest can be estimated from a pilot study or data obtained from an
experiment or from the scientific literature.
(iii) The level of significance: The probability that a positive finding is due to
chance is denoted as 𝛼, the significance level. It is usually chosen to be 0.05 or
0.01.
(iv) The desired power of the experiment: The power of an experiment is the
probability that the effect will be detected. It is usually set to 0.8 or 0.9.

Experimental design and heterogeneity issues
Experimental design: The purpose of experimental design is to plan experiment
in an effective way so that it can answer the biological question under
consideration. The

major points

to

be

considered

while

documenting

experimental plan are as follows:
(i) Biological aspects: Any biological experimental plan starts with a biological
question or hypothesis generating/ hypothesis testing. The experimenter
might have some prior knowledge of the question under study before
conducting the experiments, e.g., expression levels of some known genes,
proteins, etc., that may be helpful. Later, the question arises about the
samples such as:
6

▪

whether enough samples are available for experiment;

▪

there may be samples available before hand in some situations;

▪

availability of enough RNA, DNA or proteins from samples;

▪

whether pooling of samples is required or not;

▪

biopsies collected from same part of tissue or other tissues;

▪

whether the cell type is expressing the feature such as gene of interest;

▪

number of replicates required;

▪

effect size, etc.

(ii) Technical aspects: These include the choice of platform and avoiding
systematic errors. If the experiment has systematics errors, then the result
obtained for comparative analysis will be biased, irrespective of the precision
of measurement and the number of experimental units.
For the two above aspects, biological replicates are used to answer biological
questions and technical replicates are required to answer technical questions.
(iii) Economic aspects: These include cost of experiment and analysis, budget
available, time required to complete the experiment and its analysis, whether
pilot study is required or not, etc.
Example of a biological experiment: Let us consider an experimental study in
which there are 𝐼 conditions/groups denoted by 𝐺𝑖 (𝑖 = 1, 2, … , 𝐼) and there are 𝑁𝑖
individuals/samples denoted by 𝑆𝑖,𝑗 (𝑗 = 1, 2, … 𝑁𝑖 ) corresponding to group 𝐺𝑖
(Please see Table 2.1). Therefore, there is a total 𝑁 = ∑𝐼𝑖=1 𝑁𝑖 samples in the
experimental study. Now suppose, there are 𝐾 features (e.g., transcripts, genes,
peptides, proteins, etc.) under study (e.g., testing for differential expression,
7

testing association with trait, etc.) denoted by 𝐹𝑘 (𝑘 = 1, 2, … , 𝐾). Let 𝑦𝑖,𝑗,𝑘 is a
response outcome corresponding to sample 𝑆𝑖,𝑗 of condition 𝐺𝑖 for feature 𝐹𝑘 as
shown below in Table 2.1.
Table 2.1. An example of a biological experiment showing response outcome for
multiple features in samples across different conditions

𝐺1
𝑦1,𝑗,1

…

𝑦1,𝑁1,1

𝑦𝑖,1,1

…

𝑦𝑖,𝑗,1

…

𝑦𝑖,𝑁𝑖 ,1

𝑦𝐼,1,1

…

𝑦𝐼,𝑗,1

…

𝑦𝐼,𝑁𝐼,1

𝑦𝐼,𝑁𝐼,𝑘

𝑦1,𝑗,𝐾

…

𝑦1,𝑁1,𝐾

𝑦𝑖,1,𝐾 …

𝑦𝑖,𝑗,𝐾

…

𝑦𝑖,𝑁𝑖 ,𝐾

𝑦𝐼,1,𝐾 …

𝑦𝐼,𝑗,𝐾 …

...

…

...

𝑦𝐼,𝑗,𝑘

...

…

...

𝑦𝐼,1,𝑘

...

𝑦𝑖,𝑁𝑖 ,𝑘

...

…

...

𝒚𝒊,𝒋,𝒌

...

…

...

𝑦𝑖,1,𝑘

...

𝑦1,𝑁1,𝑘

...

...

…

...

...

𝑦1,1,𝐾 …

𝑦1,𝑗,𝑘

...

𝑭𝑲

𝑦1,1,𝑘 …

...

𝑦1,1,1 …

...

𝑺𝑰,𝑵𝑰

...

…

...

𝑺𝑰,𝒋

...

…

...

𝑺𝑰,𝟏

...

𝑺𝒊,𝑵𝒊

...

…

...

𝑺𝒊,𝒋

...

…

...

𝑺𝒊,𝟏

...

𝑺𝟏,𝑵𝟏

...

…

...

𝑺𝟏,𝒋

...

...
...

𝑭𝒌

𝐺𝐼

...

…

𝑺𝟏,𝟏
𝑭𝟏

𝐺𝑖

...

𝑦𝐼,𝑁𝐼,𝐾

There may be a variety of purposes for the experiments such as detection of
differentially expressed features, detecting association of quantitative or
qualitative trait associated features, etc.
Heterogeneity: A heterogeneous sample or population means that every
observed data has different value for the corresponding characteristic of interest.
For

example,

in

gene

expression

studies,

transcriptional

variation

is

characterized with respect to measured variables of interest such as different
conditions, different treatments, different points of time, etc. The major sources of
variations in gene expression studies are due to technical, genetic, demographic
and environmental factors [9]. There may be various factors responsible for
influencing expression in any feature (genes, proteins, etc.), some of which
cannot be measured, or some may be unknown.
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Example of heterogeneity in gene expression data: Expression in a gene can be
influenced by interaction with other genes, presence of external stimulus or
signal, etc. A gene may be highly expressed in one condition and it may be less
expressed in other condition or even sometimes it may not be expressed. In
RNA-Seq data, the biological source of RNA are tissue samples which may be
highly heterogeneous. The accuracy of the transcript quantification will depend
on the purity of samples [10]. Therefore, failure to detect such heterogeneity will
lead to false data interpretation and the result will be irreproducible.

Proteomics experiments
Proteins are important biological macromolecules performing a wide variety of
functions. The term “proteome” is defined as the entire set of proteins produced
or modified by a living organism [11, 12]. Proteomics generally refers to the
large-scale quantitative/ qualitative study of proteins for a given cell type. Now it
has emerged as a powerful tool across various fields such as biomedicine mainly
applied to diseases, agriculture and animal sciences [13-16]. It is becoming
increasingly important for the study of different aspects of plant functions, such
as identification of candidate proteins involved in the defensive response of
plants to insects, effect of global climate changes on crop production, etc. [1719]. The practical application of proteomics includes expression proteomics,
structural proteomics, biomarkers, interaction proteomics, protein networks, etc.
Proteomic expression data are generated by using high throughput
technologies

usually

involving

a

mass

spectrometer

[20-24].

Liquid

chromatography (LC) coupled with mass spectrometry (MS) is used in
9

proteomics as a method for identification and quantification of proteins and
peptides in complex mixtures. The intensity of the resulting LC-MS features is
used for relative quantification of peptides and proteins. LC-MS/MS (tandem-MS)
experiments are used to derive the sequence of peptides and deduce the protein
underlying a subset of the features. Various software tools have been developed
to extract and quantify LC-MS features from the acquired spectra, annotate the
features with sequence identity, and align the features across runs [25-32].
Samples of mixtures can be analyzed using modern LC-MS/MS systems which
are capable of identifying and quantifying thousands of peptides simultaneously.
For most of these types of experiments, the raw intensity data is summarized for
each of the replicates for each feature. Here, the feature can be either at protein
level or peptide level. Further, the data obtained from LC-MS experiments can be
used for differential expression analysis between sample groups (e.g., testing
peptides/proteins for differential abundance between subjects in a case-control
study), or to analyze protein abundance of individual biological subjects (e.g.,
unsupervised clustering or supervised classification of individuals, based on their
quantitative protein profiles).

RNA-Sequencing experiments
RNA-Sequencing, also called whole transcriptome shotgun sequencing, uses
NGS technology to reveal the presence and quantity of RNA in a biological
sample at a given moment. It has been the most productive research area from
the computational and statistical point of view that can provide an insight into the
roles of genes at transcriptomic level. It allows transcript quantification and
10

differential gene expression analysis, including identification of alternative
splicing events and post-transcriptional RNA editing events. Several machines/
protocols are available for generating RNA-Seq data, namely, Illumina (MiSeq,
NextSeq, HiSeq, NovaSeq), Ion Torrent (Proton, Personal Genome Machine),
etc. The basic steps for summarizing a typical RNA-Seq experiment are as
follows:
▪

Purified RNA is converted to cDNA, sequencing library is prepared, and
sequencing is done on an NGS platform.

▪

Millions of short read sequences are generated from one end (single-end)
or both ends (paired-end) of the cDNA fragments.

▪

These sequences are aligned to a reference genome.

▪

The number of reads mapped to known features are recorded and
summarized in a table. The features can be either genes, transcripts
(alternative

transcripts),

allele

specific

expression

or

exon

level

expression. For example, if there are F features and N samples, then a
table of read counts is a F × N matrix of non-negative integers
In RNA-Seq experiments, the samples are sequenced and resulting reads are
aligned with a reference genome. The numbers of reads mapped to each of the
reference gene are calculated. Then, normalization techniques are used to
account for the within library and between library variability. For differential
expression analysis in RNA-Seq data, the number of reads mapped to a
reference genome (read counts) are generally modelled by assuming Poisson
distribution or negative binomial distribution.
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The challenges associated with application of RNA-Seq experiments are
the problems in library construction, bioinformatics problems (storage, retrieval
and processing of large data sets, mapping and assembly problem),
sequence/transcriptome coverage versus cost, transcriptomic analysis (mapping
gene for identifying introns and exon boundaries as well as discovery of novel
transcribed

genes,

detection

of

splicing

events,

quantification

of

transcriptome/RNA expression levels to study gene expression in complex
experiments) [33].
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CHAPTER 3
STANDARDIZING

PROTEOMICS

CHROMATOGRAPHY-MASS

WORKFLOW

SPECTROMETRY:

FOR
TECHNICAL

LIQUID
AND

STATISTICAL CONSIDERATIONS

Introduction
Proteins are important biological macromolecules performing a wide variety of
functions. The proteome can be defined as the entire set of proteins translated
and/or modified within a living organism [11, 12]. Proteomics more generally
refers to large-scale LC-MS based discovery studies designed to address both
quantitative and qualitative aspects of the proteome in question. Now proteomics
has emerged as a powerful tool across various fields such as biomedicine mainly
applied to diseases, agriculture and animal sciences [13-16, 34-38]. The practical
application of proteomics includes expression proteomics, structural proteomics,
biomarker discovery, interaction proteomics, protein networks, etc. [39, 40]. Here,
we are dealing with proteomic expression data that are generated by using high
throughput technologies usually involving MS [20-24, 41].
LC-MS is used in proteomics as a method for identification and
quantification of peptides and proteins in complex mixtures [42, 43]. There are
two basic proteomics approaches, namely bottom-up and top-down [38, 44]. The
most common proteomics approach is the bottom-up in which proteins in a
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sample

are

enzymatically

digested

into

peptides

and

subjected

to

chromatographic separation, ionization and mass analysis. In the top-down
approach, intact proteins are introduced into MS where they are subjected to
fragmentation. Further, the quantification of peptides/proteins may be either
label-free or labelled (metabolic, enzymatic, or chemical) to detect differences in
protein

abundances

among

different

conditions

[45-48].

In

label-free

quantification, MS ion intensity (peak area) and spectral counting of features are
the major approaches. Conversely, top-down proteomics addresses the study of
intact proteins and consequently is most often used to address purified or
partially purified proteins [49]. Here, we are dealing with the bottom-up approach
in which peak area values have been used in label-free quantification of proteins.
Various approaches exist for proteomics data analysis in which the first
step is to summarize the intensities of all features using a quantitative summary
followed by some transformation such as log transformation to approximate it to
normal distribution. However, each of these methods has several drawbacks
which can be studied by examining the statistical properties of these methods
[50-52]. When a data set contains an equal number of subjects in each group,
and when features have no missing observations, the data set is called balanced.
It is not always the condition; sometimes the data can be unbalanced, having an
unequal number of subjects, or missing observations, or both. Missing values
(MVs) in proteomics data can occur due to biological and/or technical issues.
These are of three types: (i) missing completely at random (MCAR) in which MVs
are independent of both unobserved and observed data; (ii) missing at random
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(MAR) if conditional on the observed data, the MVs are independent of the
missing measurements; and (iii) missing not at random (MNAR) when data is
neither MCAR nor MAR [53]. The data with missing observations can be
analyzed either by excluding the features having missing observations, by using
statistical methods that can handle unbalanced data, or by using imputation
methods. If the features having missing observations are excluded, then there is
loss of information from the experiment. Therefore, the use of methods that can
handle MVs, such as imputation methods, are generally preferred. However, the
use of imputation methods may lead to wrong interpretation and still these
methods are questionable in statistical terms [54, 55].
The data set usually consists of biological replicates only or both biological
and technical replicates. Biological variability arises from genetic and
environmental factors; it is intrinsic to all organisms. The technical approaches
include sample collection and storage, sample preparation, extraction, LC
separation and MS detection [43]. Sometimes, variations in the biological data or
technical approaches to data collection lead to heterogeneity for the samples
under study [56, 57]. We performed analysis of laser capture microdissection
(LCMD)-LCMS high-resolution proteomics dataset using multifactor ANOVA
model. We studied the variability in the data based on different tissue storage
methods (TSMs) and tissue extraction methods (TEMs). We estimated the
contribution of various sources of variation to the overall variability. The study of
data variability was done using various analysis methods and transformation
and/or normalization techniques.
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We investigated the technical effects of sample preparation and the
quantitative MS resulting in heterogeneity for low abundant protein quantification.
This will improve the biomarker discovery studies utilizing limited bioreposited
tissue resources.

Methods
Proteomics experiment
Data for the methods used in the collection, extraction, and proteomic analysis
have previously been published under Hobeika L., et al. [58]. Individual data files
for MS data (.RAW), peak lists (.mgf), and compressed search results
(.mzIdentML) files can be downloaded from the MassIVE data repository
(http://massive.ucsd.edu/; MassIVE ID: MSV000079914) and ProteomeXchange
data repository [59] (http://www.proteomexchange.org/; ID: PXD004601). For
consideration of variability of the feature detection and MVs, the abbreviated
methods for these studies are provided below.
Tissue collection: Frozen (FR) and formalin-fixed paraffin embedded (FFPE)
tissue from the same human kidney unsuitable for transplant were cut into 10 μm
sections on polyethylene terephthalate membrane frame slides, stained with
Mayer’s hematoxylin and glomerular tissue compartments isolated using a Leica
LMD6500 Laser Microdissection System.
Protein extraction: Experiments were conducted to compare a single tissue
solubilization step using an acid labile surfactant to approaches for tissue
decellularization. The single step method used the acid-labile surfactant Protease
MAX surfactant with heating (MAX). Two tissue decellularization methods
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incorporated sequential decellularization with solubilization of the residual pellet
with MAX. First tissue decellularization approach used 0.4% SDS + HALT
protease/phosphatase

inhibitor

cocktail

(Thermo

Fisher)

followed

by

solubilization of residual extracellular matrix (ECM) pellet using MAX (SDS.MAX).
Second tissue decellularization approach used sequential decellularization with
25mM NH4OH/ 0.5%TritonX-100 (TX) followed by solubilization of residual ECM
pellet using MAX (TX.MAX).
Liquid Chromatography: Peptide separation was achieved using a Dionex
Acclaim PepMap 100 75µm x 2cm, nanoViper (C18, 3µm, 100Å) trap, and a
Dionex Acclaim PepMap RSLC 50µm x 15cm, nanoViper (C18, 2µm, 100Å)
separating column.

An EASY n-LC (Thermo) UHPLC system was used to

resolve peptide separation using a 140min linear gradient from 2% v/v
acetonitrile / 0.1% v/v formic acid to 40% v/v acetonitrile / 0.1% v/v formic acid.
Peptides were introduced into the Orbitrap ELITE MS using a 40mm stainless
steel emitter (Thermo P/N ES542) and a Nanospray Flex source (Thermo) was
used to position the end of the emitter near the ion transfer capillary of the mass
spectrometer.
Mass Spectrometry Data Acquisition: MS data was collected using an Nth
Order Double Play with or Electron-transfer dissociation (ETD) Decision Tree
method created in Xcalibur v2.2. Scan event one of the method obtained a
Fourier transform MS MS1 scan (normal mass range; 60,000 resolution, full scan
type, positive polarity, profile data type) for the range 300-2000m/z. Scan event
two obtained ion trap MS MS2 scans (normal mass range, rapid scan rate,
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centroid data type) on up to twenty peaks that had a minimum signal threshold of
5,000 counts from scan event one. A decision tree was used to determine
whether collision-induced dissociation (CID) ETD activation was used. An ETD
scan was triggered if any of the following held: an ion had charge state 3 and m/z
less than 650, an ion had charge state 4 and m/z less than 900, an ion had
charge state 5 and m/z less than 950, or an ion had charge state greater than 5;
a CID scan was triggered in all other cases. The lock mass option was enabled
(0% lock mass abundance) using the 371.101236m/z polysiloxane peak as an
internal calibrant.
Data Analysis with Proteome Discoverer v1.4.1.14 and Scaffold Q+S v4.4.3:
Proteome Discoverer v1.4.1.114 was used to analyze the data collected by the
mass spectrometer. The database used in Mascot v2.5.1 and SequestHT
searches was a 4/7/2015 version of the UniprotKB Homo sapiens reference
proteome canonical and isoform sequences with the 1/1/2012 version of the
common Repository of Adventitious Proteins (cRAP) database (thegpm.org)
appended to it (the cRAP database contains common contaminant proteins
observed in MS experiments). To estimate the false discovery rate (FDR), a
Target Decoy Peptide-Spectrum Match Validator node was included in the
Proteome Discoverer workflow.
The Proteome Discover was used for extraction of MS2 scan data from
the Xcalibur RAW file, separate searches of CID and ETD MS2 scans in Mascot
and Sequest, and collection of the results into a single file (.msf extension) prior
to loading into Scaffold Q+S v4.4.3. The FDR for peptides was calculated using
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the Scaffold Local FDR algorithm. Protein probabilities were calculated using the
Protein Prophet algorithm. Proteins were grouped by the Scaffold protein cluster
analysis to satisfy the parsimony principle. Label-free quantification of identified
proteins were exported as total precursor ion area values to an excel sheet for
analysis of proteomics data (Please see the file “ProteomicsData_Kidney.xlsx”).
We analyzed the data for comparing statistical methods with MVs in the
presence of heterogeneity.
Proteomics data analysis
The purpose of this study is to (1) compare variability between (a) tissue storage
methods and (b) tissue extraction methods; (2) compare various statistical
approaches of analysis and normalization methods.
We have two TSMs (FR and FFPE) and three TEMs (MAX, TX.MAX,
SDS.MAX) with three replicates and two MS runs leading to 36 samples (total
number of samples = 2 × 3 × 3 × 2 = 36). A flow chart of the experiment is given
below in Figure 3.1.

Figure 3.1. Flowchart of the proteomics experiment
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In the flowchart, we have shown the basic steps of carrying out the experiment
involving TSMs and TEMs. The MS was repeated twice to get more reliable
results for estimating experimental variability. We obtained the following six
groups as given below in the Table 3.1.
Table 3.1. Table showing different groups under study
TSM
FR

TEM
Direct
Sequential
Extraction

FFPE

MAX

1 (FR_MAX)

4 (FFPE_MAX)

TX.MAX

2 (FR_TX.MAX)

5 (FFPE_TX.MAX)

SDS.MAX

3 (FR_SDS.MAX)

6 (FFPE_SDS.MAX)

There are three replicates for each of the six groups thus leading to 18 samples.
Then, we have repeated the MS two times for the 18 samples and we obtained
six samples for each of the six groups.
Data preprocessing
Initially, there were 728 proteins identified in both runs, 380 proteins identified in
run 1 only and 342 proteins identified in run 2 only. There was a total of 1450
identified proteins out of which 1376 proteins were unique, and 37 proteins were
redundant and duplicate entries were removed from the data. Furthermore, there
were 111 proteins for which all the samples have MVs (NA values). Therefore,
we are left with protein data with 1302 proteins that correspond to 1178 gene
symbols. The percentage of NA values within each sample (36 samples) ranges
from 41.3%-78.3% with a median value of 49.5%.
As we have a greater number of groups, therefore it is difficult to perform
analysis with this data having MVs. If we discard the proteins having any MVs in
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any of the samples in a group, then there will be only 26 proteins available.
Another way is to retain the proteins having at least one or two observations in
each group. A summary of number of proteins available in each group is given
below in Table 3.2.
Table 3.2. Summary of number of proteins and missing values in different groups
Groups

No. of
proteins with
no MVs

No. of proteins
with MVs in all
samples

No. of proteins
with at least one
observation

No. of proteins
with at least two
observations

FR_MAX

448

205

1097

995

FR_TX.MAX

357

324

978

881

FR_SDS.MAX

170

678

624

454

FFPE_MAX

373

295

1007

874

FFPE_TX.MAX

353

261

1041

890

FFPE_SDS.MAX

381

237

1065

920

If we use the number of proteins having at least one observation in a
group, then we can assess a greater number of proteins. However, we need at
least two observations in each group to calculate the coefficient of variation (CV)
for a protein in each group. Therefore, we used 372 proteins which have at least
two observations in each of the six groups for further analysis.
Statistical approaches
The analysis of proteomics data becomes more complex due to non-normality
behavior of the data, and greater proportion of MVs within and across the
samples. To get a better insight of proteomics data analysis while dealing with
these problems, we have performed the analysis using three methods which are
as follows:
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A1. Method for data excluding missing values: Proteins having complete
observations for all the samples, i.e., no MVs, were used for comparison.
Proteins having MVs were discarded from the analysis.
A2. Method for data including missing values: The proteins with MVs across the
samples were analyzed using unbalanced ANOVA method [60].
A3. Method for data using imputation: The MVs were imputed after applying the
normalization methods to the data [61] as given in next section. We have used
the “impute.MAR” function of the R package “imputeLCMD” [62] for imputing the
MVs. Three different types of imputation under the assumption of MAR or MCAR,
namely, MLE [63], SVD [64] and KNN [65, 66] are available in this package. We
have used only the SVD method (A3) for imputation.
We applied three different data transformation and/or normalization methods:
N1. Logarithmic transformation: The raw data is transformed by using logarithmic
base 2.
N2. Quantile normalization (QN): It is done by using log base 2 transformation of
raw data followed by “normalize.quantiles” method [67] available in R package
“preprocessCore” [68].
N3. Variance stabilizing normalization (VSN): It is done by applying “justvsn”
function available in R package “vsn” [69] to the raw data.
Therefore, by using three methods of analysis (A1, A2 and A3) based on
three transformation and/or normalization methods (N1, N2 and N3), we have 9
different combinations (statistical approaches): excluding MVs (A1.N1, A1.N2,
A1.N3); including MVs (A2.N1, A2.N2, A2.N3); imputing MVs (A3.N1, A3.N2,
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A3.N3). We preprocessed the data using these methods to get 9 different
datasets (preprocessed data) for 6 groups having 6 samples in each group.
We calculated the CV for each protein in the groups: TSM (FR vs. FFPE),
TEM (MAX vs. TX.MAX vs. SDS.MAX) and TSM×TEM (FR_MAX, FR_TX.MAX,
FR_SDS.MAX, FFPE_MAX, FFPE_TX.MAX, FFPE_SDS.MAX). It has two
purposes: (i) Which TSM/ TEM/ TSM×TEM have the minimum CV based on
different statistical approaches; (ii) Which statistical approach leads to the
minimum CV. We have used ANOVA model as given below for studying the
contribution of variability due of TSM, TEM and the interaction term TSM×TEM:
𝑦𝑖𝑗𝑘 = 𝜇 + 𝛼𝑖 + 𝛽𝑗 + (𝛼𝛽)𝑖𝑗 + 𝜀𝑖𝑗𝑘

(3.1)

where, 𝑦𝑖𝑗𝑘 is the transformed and/or normalized data for a protein, 𝛼𝑖 (𝑖 = 1, 2) is
the ith TSM effect, 𝛽𝑗 (𝑗 = 1, 2, 3) is the jth TEM effect and (𝛼𝛽)𝑖𝑗 is the interaction
effect, TSM×TEM. The term 𝜀𝑖𝑗𝑘 is the normally distributed error component and
𝜀𝑖𝑗𝑘 ~𝑁(0, 𝜎 2 ). The mapping of the above model to the experimental design
allows us to estimate the contribution due to each source of variation for each
protein.

Results and discussion
Comparison of CV among various groups
We have 141, 372 and 372 proteins obtained by using the analysis methods A1,
A2 and A3, respectively. The summary of CV (in %) using 9 different statistical
approaches for comparisons among TSMs and TEMs is shown in Table 3.3.
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Table 3.3. Summary of CV (in %) using 9 statistical approaches among TSM and TEM
TSM

TEM

FR

FFPE

MAX

TX.MAX

SDS.MAX

6.92

2.76

3.25

3.26

7.40

(2.23, 12.77)

(2.00, 9.49)

(1.93, 9.64)

(2.05, 15.90)

(2.38, 15.24)

6.29

1.30

1.94

1.91

6.74

(0.52, 12.50)

(0.55, 5.10)

(0.34, 9.02)

(0.32, 12.67)

(0.59, 14.99)

6.25

1.28

2.03

1.95

6.81

(0.95, 12.51)

(0.48, 8.31)

(0.28, 9.33)

(0.26, 15.21)

(1.05, 15.01)

7.08

2.92

3.50

3.49

7.53

(1.23, 12.77)

(0.83, 11)

(0.65, 12.21)

(0.73, 15.90)

(0.23, 16.95)

6.62

1.75

2.71

2.49

7.17

(0.39, 12.51)

(0.52, 9.13)

(0.16, 12.16)

(0.32, 14.42)

(0.42, 16.48)

6.68

1.73

2.71

2.55

7.21

(0.80, 12.49)

(0.47, 11.16)

(0.28, 11.61)

(0.20, 15.22)

(0.76, 15.54)

7.72

3.29

4.03

3.87

8.03

(2.23, 17.47)

(1.70, 15.28)

(1.79, 15.49)

(1.72, 15.90)

(2.38, 18.01)

7.10

2.15

3.10

2.98

7.35

(0.39, 15.96)

(0.52, 13.60)

(0.45, 14.64)

(0.38, 14.42)

(0.56, 19.25)

7.07

2.13

3.10

3.04

7.35

(1.01, 18.34)

(0.47, 13.64)

(0.33, 16.02)

(0.28, 15.22)

(1.08, 18.68)

MV Excluded

A1.N1

A1.N2

A1.N3

MV Included

A2.N1

A2.N2

A2.N3

MV Imputed

A3.N1

A3.N2

A3.N3

Note: The first figure is the median value and the figures inside the parenthesis are respectively,
minimum and maximum value.

The summary of CV (in %) using 9 different statistical approaches for
comparisons among six groups of TSM×TEM is shown in Table 3.4.
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Table 3.4. Summary of CV (in %) using 9 statistical approaches among six groups of
TSM×TEM
FR_

FR_

FR_

FFPE_

FFPE_

FFPE_

MAX

TX.MAX

SDS.MAX

MAX

TX.MAX

SDS.MAX

2.64

2.71

4.73

3.00

2.87

2.34

(1.34, 8.62)

(0.83, 9.95)

(2.25, 12.90)

(1.96, 7.14)

(2.08, 13.80)

(0.75, 8.34)

0.87

1.05

2.32

0.87

0.96

0.85

(0.12, 6.26)

(0.18, 9.09)

(0.22, 10.55)

(0, 5.12)

(0, 7.28)

(0, 8.13)

0.77

1.01

2.37

0.84

0.95

0.83

(0.17, 7.53)

(0.13, 9.87)

(0.32, 11.92)

(0.12, 6.14)

(0.18, 11.75)

(0.10, 8.10)

2.64

2.81

4.49

2.97

3.01

2.41

(0.05, 11.71)

(0.14, 10.93)

(0.03, 19.81)

(0.09, 13.33)

(0.15, 13.8)

(0.17, 17.14)

1.08

1.47

2.88

1.28

1.32

1.14

(0, 10.62)

(0, 9.33)

(0.07, 16.32)

(0, 10.50)

(0, 12.62)

(0, 13.32)

1.09

1.39

2.44

1.28

1.41

1.19

(0.04, 9.67)

(0.04, 9.87)

(0.02, 17.52)

(0.01, 9.55)

(0.12, 12.45)

(0.07, 17.72)

2.94

3.26

5.06

3.40

3.33

2.86

(0.95, 16.56)

(0.83, 15.27)

(2.25, 17.75)

(1.34, 16.87)

(0.62, 15.62)

(0.69, 16.21)

1.59

1.83

2.77

1.78

1.70

1.75

(0.24, 17.06)

(0.06, 14.28)

(0.20, 19.86)

(0.02, 15.03)

(0.02, 14.08)

(0.03, 14.23)

1.57

1.82

2.48

1.74

1.7

1.63

(0.14, 19.00)

(0.19, 15.69)

(0.32, 17.28)

(0.07, 14.88)

(0.21, 14.28)

(0.16, 15.38)

MV Excluded

A1.N1

A1.N2

A1.N3

MV Included

A2.N1

A2.N2

A2.N3

MV Imputed

A3.N1

A3.N2

A3.N3

Note: The first figure is the median value and the figures inside the parenthesis are respectively,
minimum and maximum value.

TSM: We found that median value of CV is lowest in FFPE using all the statistical
approaches. Furthermore, within FFPE, the normalization method N3 has the
minimum value of median CV for each analysis method. Overall, the minimum
median CV is for A1.N3 in FFPE.
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TEM: We have the minimum median value of CV in TX.MAX. We found A1.N2
has the minimum value of median CV.
TSM×TEM: We have the minimum median value of CV in FR_MAX followed by
FFPE_SDS.MAX using all the approaches. We found A1.N3 has the minimum
value of median CV in all the groups except for A1.N2 in FR_SDS.MAX. Overall,
the minimum median CV is for A1.N3 in group FR_MAX.
Based on median CV, FFPE is a better choice than FR using all the
statistical approaches. Similarly, among TEMs, TX.MAX has the least CV and
can be a better choice. However, based on the maximum value of CV, MAX is a
better choice for TEM. If we consider approaches (A2 & A3) having greater
number of

proteins and TEM within

FFPE, we

see that A3.N3

in

FFPE_SDS.MAX is having the least median CV (1.63).
Contribution of Sum of Squares (SS) due to each component
The percent contribution of SS due to each variable to the total SS was
computed for each protein. A summary of contribution of each variable to the
total variability is given below in Table 3.5.
Table 3.5. Summary of the contribution of % SS due to TSM, TEM and TSM×TEM
SSTSM

SSTEM

SSTSM×TEM

9.86

20.9

32.87

(0, 68.98)

(0.47, 36.32)

(0.29, 54.41)

14.71

27.49

43.21

(0, 78.88)

(1.35, 48.44)

(0.92, 64.54)

15.05

26.7

41.88

(0, 73.78)

(2.31, 44.92)

(0.59, 65.23)

MV Excluded

A1.N1

A1.N2

A1.N3
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10.84

20.97

33.46

(0, 83.65)

(0.08, 49.47)

(0.29, 78.05)

12.59

25.56

39.37

(0, 85)

(0.06, 54.68)

(0.08, 80.29)

12.84

25.72

40.32

(0, 88.18)

(0.04, 53.37)

(0.06, 77.54)

8.52

18.83

29.86

(0, 73.76)

(0, 40.46)

(0.09, 57.77)

11.07

23.53

37.33

(0, 85.67)

(0.03, 50.93)

(0.05, 65.75)

11.18

23.32

37.26

(0, 85.31)

(0, 49.68)

(0.14, 65.32)

MV Included

A2.N1

A2.N2

A2.N3

MV Imputed

A3.N1

A3.N2

A3.N3

Note: The first figure is the median value and the figures inside the parenthesis are respectively,
minimum and maximum value.

We found that the TSM has the least contribution to the total variability whereas
interaction term has the maximum contribution (SSTSM < SSTEM < SSTSM×TEM).
The imputation method leads to decrease in the SS contribution due to each
variable.
The proportion of proteins showing significant effects due to TSM, TEM
and TSM×TEM using 9 different approaches are given in Table 3.6.
Table 3.6. The summary of proportion of proteins showing effects due to the variables:

MV Excluded

TSM, TEM and TSM×TEM
NTSM

NTEM

NTSM×TEM

A1.N1

0.65/ 0.62/ 0.33

0.77/ 0.76/ 0.5

0.77/ 0.77/ 0.65

A1.N2

0.84/ 0.84/ 0.72

0.91/ 0.91/ 0.77

0.89/ 0.88/ 0.78

A1.N3

0.82/ 0.82/ 0.71

0.87/ 0.87/ 0.72

0.87/ 0.85/ 0.77
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MV Included

A2.N1

0.61/ 0.57/ 0.25

0.72/ 0.72/ 0.28

0.79/ 0.79/ 0.49

A2.N2

0.75/ 0.73/ 0.48

0.83/ 0.82/ 0.58

0.87/ 0.87/ 0.68

A2.N3

0.74/ 0.74/ 0.52

0.81/ 0.81/ 0.6

0.85/ 0.84/ 0.67

MV Imputed

A3.N1

0.58/ 0.53/ 0.24

0.69/ 0.67/ 0.35

0.78/ 0.77/ 0.52

A3.N2

0.71/ 0.68/ 0.48

0.81/ 0.8/ 0.58

0.86/ 0.85/ 0.69

A3.N3

0.7/ 0.69/ 0.49

0.8/ 0.78/ 0.58

0.84/ 0.83/ 0.67

Note: The result obtained using p-values corresponding to without adjustment, BH adjusted and
Bonferroni adjusted are separated serially by slash “/” in the table.

The proportion of proteins showing significant effects due to TSM and TEM and
their interaction vary with each statistical approach. The TSM has the least
proportion of significant proteins as compared to those of TEM and TSM×TEM.
This shows that TSM has the least influence. Furthermore, the imputation
approach has the least proportion of significant proteins. This shows that
imputation of MVs is a better approach for analysis as it leads to reduction in
variability and increase in the number of proteins assessed for analysis.
Analysis for imputed data using VSN
We used ANOVA to test the significance of proteins based on TSM and TEM.
The plot of CV (in %) of the proteins in increasing order of p-values based on
A3.N3 for TSM and TEM are respectively given in Figures 3.2 and 3.3.
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Figure 3.2. Plot of CV (in %) versus the proteins with increasing order of p-values for
TSM (FR and FFPE)

Figure 3.3. Plot of CV (in %) versus the proteins with increasing order of p-values for
TSM (MAX, TX.MAX and SDS.MAX)

There are respectively 261 and 296 proteins showing significant effects
due to TSM and TEM. From Figure 3.2, we see that FR has more CV as
compared to that of FFPE for most of the proteins. From Figure 3.3, we found
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SDS.MAX has more CV as compared to those of MAX and TX.MAX. We applied
chi-square test for the proteins having significant effects due to TSM and TEM.
We found that there is association between the TSM and the CV (p-value <
0.001). Similarly, in case of TSM, we found that there is association between the
variables, TEM and CV (p-value < 0.001).
We found that the FFPE is a better method than that of the FR for tissue
storage. Further, we found that MAX, the single step approach is better than
those of two-step approach for tissue extraction. The maximum contribution to
the total variability is due to the interaction effect TSM×TEM and TEM. The TSMs
and TEMs have significant effects on the protein expression. However, the effect
due to TSM is the least. In the present article, we have used different analysis
and normalization methods for the proteomics data. The number of proteins for
testing can be increased by either by including the MVs (A2) or by using imputed
data (A3). The imputation method (A3) has the least SS contribution than those
of A1 (complete data) and A2 (unbalanced data). We found the least proportion
of significant proteins when using the imputation method (A3). The normalization
method N1, i.e., only logarithmic transformation is not suited for analyzing the
proteomics data. The other normalization methods N2 and N3 having lesser CV
can be a better approach.

Conclusion
Our study discussed the technical issues with a focus on the statistical analysis.
It will provide better insight to the researchers while designing and executing
experiments. There may be small changes caused during sample handling and
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storage, different batches of buffer, electrospray, instrument components,
calibration and tuning, etc. While designing any proteomics experiment, we must
identify the variability associated with technical steps. The researchers involved
in proteomics research area can use this data for further study. The data can
further be used for planning new proteomics experiments. In the future, we will
come up with a rigorous statistical approach using different proteomics dataset
that could overcome the heterogeneity problem caused due to technical reasons
in the proteomics data with MVs. We found that the CVs obtained using all the
approaches is lesser for FFPE as compared to those of FR. Among the TEMs,
we found that TX.MAX has the least value based on median CV and MAX has
the least value based on maximum CV. The normalization methods N2 and N3
have lesser CV as compared to that of logarithmic transformation. Based on SS,
we found that the TSM has the least contribution to the total variability. The
imputation of MVs leads to reduction in variability and increase in the number of
proteins assessed for analysis. Therefore, we can recommend: (i) FFPE is the
better choice than FR for tissue storage, (ii) one-step TEM is better than the twostep TEM, (iii) Imputation method (A3) is the best approach, (iv) N2 or N3
method of normalization should be the preferred choice.
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CHAPTER 4
INTERACTIVE

WEB

TOOL

FOR

STANDARDIZING

PROTEOMICS

WORKFLOW FOR LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY
DATA

Introduction
Standardization of experimental workflow is an essential task for carrying out
proteomics experiments [4, 70]. There are various technical steps involved in
proteomics experiments such as sample collection, sample storage, sample
preparation, extraction, liquid chromatography (LC) - mass spectrometry (MS)
detection. The experimenters have various choices available for each step in the
proteomics workflow. Therefore, it becomes necessary to find the most suitable
choice for each step in the proteomics workflow. LC-MS is used in proteomics as
a method for identification and quantification of features (peptides/proteins) in
complex mixtures [42, 43]. There are several challenges associated with the
proteomics data such as data heterogeneity due to technical reasons, MVs and
low-abundant features. Furthermore, the proteomics data can be the balanced
(equal number of observations in each group) or unbalanced (unequal number of
observations in each group). The data can be unbalanced due to unequal
number of subjects, or missing observations, or both. The missing values (MVs)
in proteomics data can occur due to biological and/or technical issues.
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The missing observations are broadly categorized as missing completely at
random (MCAR), missing at random (MAR) and missing not at random (MNAR)
[53].
Various studies have been done for studying the data variability,
standardization and quality control of proteomics expression data [56, 71-73].
However, only a few tools exist for the standardization and quality control of
proteomics expression data based on different approaches [74-76]. Therefore,
we have developed a user-friendly tool for standardizing the proteomics workflow
and studying the variability in proteomic expression data generated by high
throughput technologies involving MS [20, 22, 24, 41]. We use the special cases
of general linear model (GLM), analysis of covariance (ANCOVA) and analysis of
variance (ANOVA) to study the data variability. The user can estimate the
contribution of various sources of variation to the overall variability. The study of
data variability can be done using various analysis methods and normalization
techniques. The user can analyze the data either by excluding the features
having missing observations or by imputing the MVs. Excluding the features
having missing observations leads to loss of information from the experiment.
Therefore, we have provided two imputation methods to include more features in
the analysis. We have demonstrated the tool using simulated proteomics data
comprising of 1000 peptides corresponding to 200 proteins. We implemented all
the steps in R [1] and used “shiny” package [3] for developing the web
application. The PWST tool can be accessed freely by the users from
https://ulbbf.shinyapps.io/pwst/.
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Methods
The steps and various options available under each step are described below.
More details about all the steps are given in the next section.
1. Upload the proteomics expression data
2. Feature type: The analysis can be done either at protein level or peptide level.
After uploading the expression data file, the user has to select the feature type.
3. Aggregation method: We have provided four options for data aggregation: (i)
Mean, (ii) Median, (iii) Sum, (iv) Maximum. Data aggregation is required if the
user has provided the peptide data and wants analysis at protein level. It is also
applicable to other situations, such as when the features (proteins or peptides)
are redundant. For example, if the user uses more than one database for
searching features, there may be many redundant features.
4. Upload the additional information: The user has to upload the additional
information about the data. This file contains the information of the samples and
the variables under study. The variables may be categorical and/or continuous
(numeric).
5. Choose the categorical variables: The user has to select the categorical
variables which will automatically pop out after the file containing additional
information has been uploaded. Categorical variables contain a finite number of
categories/groups. Examples of the categorical variables in proteomics workflow
are: storage methods, extraction methods, etc.
6. Choosing the numeric variables: After selecting the categorical variables, the
user can now select the numeric (continuous) variable from the remaining
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variables, if available. The variable may contain any value within some range.
Examples of numeric variables are age, weight, height, etc. of the individuals.
7. Analysis method: We have provided two options for the analysis:
(i) Excluding missing values: Features having MVs in any of the samples are
discarded from the analysis. The features having observations in all the samples
are retained for analysis. This approach may not be appropriate as it will exclude
many features. Therefore, we have provided the imputation methods.
(ii) Imputing missing values: The MVs are imputed after applying the
normalization methods to the data [61] as given in next section. We have
provided two imputation methods under the assumption of MAR or MCAR,
namely, SVD [64] and KNN [65, 66] available from the “impute.MAR” function of
the R package “imputeLCMD” [62]. We impute the data at protein level if the data
is available at protein level. Otherwise, we impute the data at peptide level. In
case, if the analysis is to be done at protein level for the peptide data, then we
first impute the data at peptide level and then aggregate the data. By default, the
imputation is done globally. However, the user can apply the imputation methods
group wise by specifying additional column “Norm_Imp_Group” and the group
numbers in the file containing additional information.
8. Transformation/Normalization method: There are four options available for
data transformation and/or normalization:
(i) Logarithmic transformation: The raw data is transformed by taking log base 2.
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(ii) Quantile normalization (QN): This method is applied on log base 2
transformed data using the “normalize.quantiles” method [67] available in R
package “preprocessCore” [68].
(iii) Variance stabilizing normalization (VSN): This method is applied on the raw
data using “justvsn” function available in R package “vsn” [69].
(iv) None: In some situations, if the user wants to use his own normalized data,
then he can use the “None” option.
By default, the normalization methods (QN and VSN) are applied globally. The
user can apply the normalization methods (QN and VSN) group wise by
specifying additional column “Norm_Imp_Group” and the group numbers in the
file containing additional information.
9. Level of significance: The user can specify the level of significance (𝛼). By
default, the level of significance is 0.05.
10. Method of adjustment: The user must adjust the p-values for multiple testing
of features for which we have provided the following options: “BH”, “bonferroni”,
“holm”, “Hochberg”, “hommel” and “BY”. The method “BH” is the default
adjustment method.
The user has to hit the “Submit” button after specifying the abovementioned inputs. The user will get the following results under different tabs:
1. Inputs selected: It shows the various inputs defined by the user for the
analysis.
2. Visual plots of the preprocessed data: We provide exploratory plots of the
preprocessed data such as box plot, density plot, correlation heatmap.
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3. The sum of squares (SS) results: We fit the ANOVA/ ANCOVA model with
fixed effects for each feature. The results are comprised of: (i) A table showing
the contribution of SS due to each variable, the p-values and the adjusted pvalues corresponding to each variable, (ii) summary of % contribution of SS and
(iii) box plot showing % contribution of SS due to each variable.
4. The coefficient of variation (CV) analysis: We calculate the CV (in %)
corresponding to the groups within each categorical variable. The results consist
of: (i) A table showing the CV of different groups of each categorical variable for
all the features, (ii) summary of CV and (iii) box plot showing CV under the
various groups of categorical variables.
5. Number of significant features: We provided a table showing the number of
features without and with adjustment which have significant effect due to each
variable.
All these results can be viewed and downloaded. The complete demonstration of
the tool is discussed in next section.

Demonstration and discussion
We used a simulated dataset generated with the aid of the kidney proteomics
expression data (used in Chapter 3) for demonstrating our tool. We generated a
proteomics expression data set that consists of 200 proteins with 1000 peptides.
Suppose there are two steps (M1 and M2), e.g., tissue storage method and
tissue extraction method, involved in an experiment. Our purpose is to study the
variability associated with the two steps/ variables/ methods. Furthermore,
suppose we have respectively two approaches of M1 (A1 & A2) and three
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approaches of M2 (B1, B2 & B3). Now our purpose is to select the most suitable
approach for M1 and M2. In the example dataset, we have respectively two
levels of M1 and three levels of M2 each with three biological replicates. The MS
is repeated two times so that we have total 36 samples. We have included “Age”
of the subjects (biological replicates) as a numeric (continuous) variable. The
screenshot of the PWST tool is shown below in Figure 4.1.

Figure 4.1. Webpage of the tool “PWST”

38

Inputs to be specified by the user
1. Upload the expression data: The user has to upload the proteomics
expression data either in csv, tsv, txt, xls or xlsx format. The first two columns are
reserved for proteins and peptides. Even if the data is available at protein level
only and there is no peptide data, then the user must leave the second column
blank. The expression data must start from the third column and onwards. The
first row must contain the labels such as “Protein”, “Peptide” and the sample
names (from third column). After the first row, we have the name of proteins and
peptides in the first and second column respectively. In the remaining portion, we
have the expression values of corresponding features (proteins/ peptides) and
samples. A portion of input expression data is shown below.

Figure 4.2. A portion of proteomics expression data

The user has to click on the “Browse…” button and select the file to upload the
expression data as given below in Figures 4.3:

Figure 4.3. Upload the proteomics expression data
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2. Feature type: After uploading the expression data file, the user has to select
the feature type. The feature type available will automatically be detected. In the
given example, we have the peptide data. So, there are two options available:
“Protein” or “Peptide”. We selected the analysis to be done at “Protein” level as
given below:

Figure 4.4. Choose the feature type – “Protein” or “Peptide”

3. Aggregation method: There are four options available for data aggregation: (i)
Mean, (ii) Median, (iii) Sum, (iv) Maximum. We selected “Mean” for aggregating
the peptide data at protein level as given below:

Figure 4.5. Choose the aggregation method (Mean/Median/Sum/Max)

4. Upload the additional information: Now the user has to upload the additional
information about the data either in csv, tsv, txt, xls or xlsx format. This file
contains the information of the samples and the variables under study. The
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variables may be categorical and/or numeric (continuous). A portion of additional
data is shown below.

Figure 4.6. A portion of additional information of data

The user has to click on the “Browse…” button and select the file to upload the
additional data as given below:

Figure 4.7. Upload the additional information of data

5. Choose the categorical variables: The user has to select the categorical
variables one by one which will automatically pop out after the file containing
additional information has been uploaded. We have selected “M1” and “M2” as
the categorical variables under study as shown in Figure 4.8.
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Figure 4.8. Selection of categorical variables

6. Choosing the numeric variables: After selecting the categorical variables, the
user can now select the continuous variable from the remaining variables, if
available. In this example, we have selected “Age” as given below.

Figure 4.9. Selection of numeric variables

7. Analysis method: We have provided two options for the analysis: (i) Excluding
missing values and (ii) Imputing missing values. Further, there are two methods
of data imputation available: (a) SVD and (b) KNN. We selected the radio button
“Imputing missing values” and “SVD” method for data imputation. The
screenshots are given below.

Figure 4.10. Selection of analysis method
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8. Transformation/Normalization method: There are four options available for
data transformation and/or normalization. We selected “Variance Stabilizing
Normalization” for data normalization as given below.

Figure 4.11. Selection of normalization method

9. Level of significance: The user has to specify the level of significance. We
have selected the default value 0.05 as the level of significance.

Figure 4.12. Specify the level of significance

10. Method of adjustment: The user has to select the method of adjusting the pvalues for multiple testing of features. We have provided six adjustment methods.
We selected “BH” adjustment method.

Figure 4.13. Specify the adjustment method

After specifying all the inputs, the user has to hit the “Submit” button and wait for
the results.
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Results obtained
1. Inputs selected: The various inputs defined by the user for the analysis can be
viewed as given below.

Figure 4.14. Inputs selected

2. Visual plots of the preprocessed data: The various exploratory plots of the
preprocessed data such as box plot, density plot, correlation heatmap can be
viewed under each tab as shown in Figures 4.15-4.17.

Figure 4.15. Box plot of preprocessed expression data
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Figure 4.16. Density plot of preprocessed expression data

Figure 4.17. Interactive correlation heatmap of preprocessed expression data

From the box plot and density plot, we find that the data normalized using the
“VSN” normalization method and analysis using “SVD” imputation method are
normally distributed for all the samples. Here, we have normalized and imputed
the data group wise.
The correlation heatmap shows correlation between the samples and the
corresponding p-values.
3. The SS results: (i) The results showing the contribution of SS squares due to
each variable, the p-values and the adjusted p-values corresponding to each
variable are shown below. If the input is peptide data and analysis is at “Protein”
level, the table will also show the number of peptides corresponding to each
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protein. The complete SS result can be downloaded by clicking on the
“Download_Result_SS_Features” link.

Figure 4.18. Contribution of SS due to each variable, the p-values and the adjusted p-values
corresponding to each variable for each protein

(ii) The result summary of % SS contribution due to each variable is shown below
in Figure 4.19.

Figure 4.19. Summary of % SS contribution due to each variable

(iii) The box plot showing % contribution of SS due to each variable is given in
Figure 4.20.
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Figure 4.20. The box plot showing % contribution of SS due to each variable

From the summary and box plots, we found that the SS contribution due to the
variable M2 is more than that of variable M1. The variable “Age” has the least SS
contribution.
4. The CV analysis: We calculate the CV corresponding to the groups within
each categorical variable. We obtained the following results: (i) CV of different
groups of each categorical variable for all the proteins, (ii) Summary of CV (%)
for all the proteins, and (iii) Box plot showing CV under the various groups of
categorical variables. These results are shown in Figures 4.21-4.23.

Figure 4.21. The CV (in %) of different groups of each categorical variable for all the proteins
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Figure 4.22. Summary of CV (in %) for all the proteins

Figure 4.23. Box plot showing CV (in %) under the various groups of categorical variables

The summary and box plots of CV show that (i) within variable M1, A2 has lesser
variability that of A1 and (ii) within variable M2, B2 has the least variability among
the three approaches of M2.
5. Number of significant features: A table showing the total number of proteins
assessed and the number of proteins which have significant effect due to each
variable, “M1”, “M2” and “Age”, without and with adjustment is shown below.

Figure 4.24. Summary of significant proteins
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We found greater number of proteins showing significant effects due to M2 than
that of M1. This further shows that variable M2 has more significant effect than
that of M1. The variable “Age” has very less effect, i.e., only two protein showed
significant effect due to “Age”.
The user can download the results under each tab by clicking on the
download links provided under each tab. The tables will be downloaded in “xlsx”
format and the plots will be download in “png” format.
We analyzed the data at the protein level using VSN normalization and the
SVD imputation method. By providing various inputs to the tool, the user gets
various results. Based on the summary and box plots of SS, we found that the
SS contribution due to the variable M2 is more than that of variable M1. We
found that the variable “Age” has the least SS contribution. Furthermore, the
summary and box plots of CV show that (i) within variable M1, A2 has lesser
variability that of A1 and (ii) within variable M2, B2 has the least variability among
the three approaches of M2. Therefore, we can conclude that (i) approach A2 is
better that that of A1 for the method M1, (ii) approach B2 is better than those of
B1 and B3 for the method M2.

Conclusion
Our tool provides a user-friendly approach to standardize proteomics workflow
using multiple statistical approaches. The user can identify the variable with
greater variability based on SS as well as the best approach for the steps
involved in the proteomics workflow based on the CV. The tool will be helpful to
the researchers for designing and executing experiments.
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CHAPTER 5
INTERACTIVE TOOL FOR STATISTICAL ANALYSIS OF LABEL-FREE LC-MS
PROTEOMICS

DATA

CONSIDERING

MISSING

VALUES

AND

HETEROGENEITY

Introduction
Identification, quantification, and characterization of peptides and proteins from
biological samples are important for understanding the molecular processes
governing the cell physiology and pathophysiology [11]. With the introduction of
high

throughput

technologies

such

as

ultra-high-performance

liquid

chromatography coupled to high resolution mass spectrometers [24, 41], the high
mass accuracy proteomics data can be reliably generated from samples and
further processed and modeled using various statistical approaches. However,
the heterogeneity in the LC-MS data due to variations in the biological samples
or technical approaches can be problematic for accurate biological modeling [56].
Here, we are dealing with expression proteomics including the analysis of
features (peptides and/or proteins) at large scale. Differential expression (DE)
analysis of features is carried out to detect significant features in two or more
conditions, such as healthy versus different disease conditions. Despite the
availability of tools for analyzing proteomics data [57, 77-79], there are various
statistical challenges in analyzing proteomics data, such as data heterogeneity
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and missing values (MVs) [52, 55]. The biological variability among the samples
and technical approaches of data generation lead to heterogeneity. Biological
variability arises from genetic and environmental factors. The technical
approaches such as sample extraction, storage, different batches of buffer,
repeating mass spectrometer runs, etc., lead to changes in the expression data.
Therefore, biological and technical variability along with other covariates such as
race, gender, age, height, etc., should also be taken in account in the analysis.
Furthermore, there is problem of MVs in the proteomics data that can occur due
to biological and/or technical issues. There are three broad categories of MVs,
namely, MCAR, MAR and MNAR [53].
Here, we introduce a user-friendly shiny tool to analyze and compare
proteomics expression data scalable from small cell-culture based studies to
large clinical proteomic studies using various statistical approaches. We have
enabled the use of various input parameters to perform DE analysis by various
approaches. Our tool will be helpful to detect differentially expressed features
while considering the variability due to biological and technical replicates as well
as missing observations. We have provided options to adjust the effect due to
additional covariates such as age, race, etc. We have implemented the methods
in R [1]. The tool has been made using “shiny” package [3]. The interactive plots
were implemented using “plotly” [80].

Methods
We have provided various options at each step to perform the data analysis. The
two main pipeline inputs required for our platform are label-free proteomics
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expression data and the additional pre-clinical or clinical information, such as
patient demographic covariates. The various steps in the workflow of DE analysis
of proteomics data are given below.
1. Upload the proteomics expression data
2. Select the type of feature for the analysis: The analysis can be done either at
the protein or peptide level. So, the user then selects either “Protein” or “Peptide”
for the analysis.
3. Select the aggregation method (Mean/Median/Sum/Max): Data aggregation is
required if the user has provided the peptide data and wants analysis at the
protein level. It is also applicable to other situations, such as when the features
are redundant.
4. Upload the additional information of the data: The additional information of the
data such as samples, groups, biological samples, etc., is required for the
analysis. In complex experiments, there can be other independent variables
present such as run, biological replicate, gender, age, etc. We have provided the
user a method to include these variables in such situation. After the file is
uploaded, the user must specify the nature of variables.
5. Select the categorical fixed effect: The fixed effects are the effects that remain
constant across individuals. Here, the user has to select the categorical fixed
effects such as groups, genotype, race, gender, etc.
6. Select the numeric (continuous) fixed effect: The user has to select the
numeric (continuous) fixed effects such as age, height, etc.
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7. Select the random effects: The random effects are the effects that are random
and unpredictable. The random effects cannot be controlled by the experimenter,
e.g., MS run, biological replicates, technical replicates, etc.
8. Select the categorical fixed effect of interest: The user has to specify the
variable of interest which is considered to have a fixed effect.
9. Select a comparison of interest: After selecting the categorical fixed effect of
interest, all the available pairwise comparisons will appear in the drop-down
menu. The user can select one comparison at a time.
10. Choose the method of analysis:
(i) Excluding MVs: We retain the features having complete observations for all
the samples. The features with MV in any of the samples are discarded from the
analysis. However, this approach is generally not preferred as it leads to
exclusion and loss of various features. Therefore, we have provided the option of
imputing MVs.
(ii) Imputing MVs: We provide a hybrid imputation method of the R package
“imputeLCMD” [62] that assumes the MVs are both MAR and MNAR. We have
given the users two different options for data imputation under the assumption of
MAR or MCAR, (a) Singular value decomposition [64]

and (b) K-nearest

neighbor [65, 66]. The MNAR assumption uses a quantile regression method for
the imputation of left-censored missing data in quantitative proteomics. The MVs
are imputed for each group separately after normalizing the data [61].
11.

Choose

the

transformation

and/or

normalization

methods:

Data

transformation and/or normalization is required to achieve consistency across the
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samples. The normalization is done group-wise, based on the variable of interest.
We have provided the following options:
(i) Logarithmic transformation: The raw data are transformed to log base 2.
(ii) Quantile normalization: The raw data are transformed to log base 2 followed
by QN using the function “normalize.quantiles” [67] of the R package
“preprocessCore” [68].
(iii) Variance stabilizing normalization: The raw data are normalized by using the
“justvsn” function of the R package “vsn” [69], separately for each group.
(iv) None: The users can use their own normalized data in place of raw intensity
data.
12. Method of DE analysis: We have provided various options to detect
differentially expressed features. It is assumed that the data follow normal
distribution after applying the data transformation and/or normalization method.
The user must select the appropriate test, depending on the experimental design,
which are discussed below.
(i) LIMMA/Moderated t-test: We have used “limma” R package [81]. This is the
most robust statistical analysis method. We fit the linear model using “lmFit”
function for each feature. The moderated t-statistics and the coefficient estimates
are computed by using empirical Bayes (eBayes) method [82, 83]. The featurewise residual variances are squeezed toward a common value using eBayes
method. However, this method can handle only a single random effect.
(ii) Linear fixed or mixed model approach: A general linear approach with fixed
and random effects is a much more flexible and powerful technique that can be
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applied to more complex designs. If random effects have been specified by the
user, then we fit the linear mixed-effects models using R package “lme4” [84].
We have used R package “afex” for estimating the mixed models and calculating
the p-values of fixed effects [85]. This option can also handle more than one
variable having random effects. In the absence of any random effect, we fit a
linear model using the “lm” function [1]. The contrasts of the estimated marginal
means for linear and mixed models are computed using R package “emmeans”
[86].
(iii) Pairwise t-tests: On clicking the radio button “T-test”, a dropdown menu
showing three different types of t-test will appear. The three types of t-test are
given below:
(a) Two sample t-test assuming equal variances: This option performs t-test with
the assumption that the two populations have equal variances with equal and
unequal samples sizes.
(b) Two sample Welch’s t-test assuming unequal variances: The Welch’s t-test is
used when the population variances are assumed to be unequal. The sample
sizes may be equal or unequal.
(c) Paired t-test: This option performs the paired t-test. This test is used to
compare two population means from the same population at two different times
(repeated measures) or to compare two population means from different
populations in which the observations have been matched or “paired”.
If the user chooses options, t-test or Welch’s t-test, the test will consider only the
fixed effect of interest. The analysis will not control the effects of other variables.
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If the user wants to control the effects due to other variables, then the user must
choose the options (i) LIMMA/moderated t-test or (ii) linear fixed/mixed model
approach. If there is only one fixed effect and no other covariates, then the first
option gives the result based on moderated t-test, whereas the second option
gives the result equivalent to Welch’s t-test.
13. Select the significance level: By default, it is 0.05. However, the user can
specify any cut-off between 0 and 1.
14. Desired log2 fold change (FC) cut-off: We have assumed the data is
approximately on log 2 scale for easier interpretation of the results. The user can
specify a desired log2 FC cut-off. By default, the value of log2 FC is 1, which
means a doubling in intensity (abundance values).
15. Method of adjustment: We have provided several methods of adjusting pvalues for testing multiple features available in R [1]. These are BenjaminiHochberg (BH), Bonferroni, Holm, Hochberg, Hommel, and Benjamini-Yekutieli
(BY). The BH method is the default adjustment method.
After specifying all the input parameters, the user has to hit the “Submit”
button to get the results. The results are displayed under each tab. The tab
“Inputs selected” contains the various input parameters provided by the user. We
provide various exploratory plots such as box plot, density plot, correlation
heatmap and multidimensional scaling (MDS) plot. The summary of differentially
expressed features can be viewed under “Summary” tab. The user can view the
result of DE analysis under the tab “Table of differentially expressed features”.
We provide interactive volcano plots for both with and without adjustment. All the
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results can be download by clicking on the download links provided under each
tab. The summary and table of differentially expressed features are downloaded
in “xlsx” format. By clicking on the download link under “Table of differentially
expressed features”, the user will obtain the DE analysis result, complete results
having the overall F-statistic, p-value and other values for different contrast or
comparison, and the preprocessed data. All the plots are downloaded in “png”
format.

Demonstration and results
To demonstrate our web-based application, we generated a test proteomics
expression data set abstracted from locally available clinical proteomics data sets
consisting of 200 proteins corresponding to 1000 peptides. The additional data
information file contains the information with headings, “Samples”, “Group”,
“Race”, “Bio”, “Run” and “Age”. The “Group” is the fixed effect of interest. There
are three groups, namely, control, case1 and case2, each having three biological
replicates with two MS runs. Thus, there are six samples in each group leading to
total 18 samples. After specifying the input parameters and submitting the job,
we obtained various results such as results summary, result showing
differentially expressed features, graphical plots (box plots, density plots,
correlation heatmap, MDS plot, volcano plots). The steps involved in the analysis
with screenshots are as follows.
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Figure 5.1. Webpage of the tool “SATP”

Input specifications
We have demonstrated the webtool using a test proteomics dataset. The inputs
to be provided by the user are as follows:
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1. Upload the proteomics expression data: The first step is to upload the
proteomics expression data either in csv, txt, tsv, xls or xlsx format. The first two
columns are reserved for proteins and peptides. If the data are available at the
protein level only and there are no peptide data, then user must leave the second
column blank. The expression data must start from the third column and
onwards. The first row must contain the labels such as “Protein”, “Peptide”
followed by the sample names (starting from third column). A portion of input
expression data is shown below.

Figure 5.2. A portion of proteomics expression data

The user has to click on the “Browse…” button for selecting the expression data
file as given below in Figure 5.3.

Figure 5.3. Upload the proteomics expression data
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2. Select the type of feature for the analysis: The feature type available will
automatically be detected after uploading the expression data file. There are two
options available: “Protein” or “Peptide”. We selected the analysis to be done at
“Protein” level as given below.

Figure 5.4. Choose the type of feature– “Protein” or “Peptide”

3. Select the aggregation method: There are four options available for data
aggregation (Mean/Median/Sum/Maximum). We selected “Mean” for aggregating
the peptide data at protein level as given below.

Figure 5.5. Choose the aggregation method

4. Upload the additional information: Now the user has to upload the additional
information about the data either in csv, txt, tsv, xls or xlsx format. The first row
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must contain the labels of various information. The first column contains the
sample names. The screen shot of the additional data is shown below.

Figure 5.6. Additional information of data

In the given example, labels in the first row are: “Samples”, “Group”,
“Gender”, “Race”, “Bio”, “Run”, “Age”. There are three groups (column with label
“Groups”), namely, “Control”, “Case1” and “Case2”, each having three biological
replicates (column with label “Bio”) with two MS runs (column with label “Run”).
There are six samples in each group leading to total 18 samples (column with
label “Samples”). There are three additional covariates (gender, race and age) in
the data. The covariates gender (column with label “Gender”) and race (column
with label “Race”) are categorical fixed effects, each having two levels. Gender
has two levels: “Male” and “Female”. Race has two levels: “White” and “Black”.
The covariate age (column with label “Age”) is continuous/numeric fixed effect.
The file can be uploaded by first by clicking on the “Browse…” button and
then selecting the file as given in Figure 5.7.
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Figure 5.7. Upload the file with additional information of data

5. Select the categorical fixed effect: The user has to select the categorical fixed
effects one by one which will automatically pop out after uploading the file
containing additional information. We have selected “Group” and “Race” as the
categorical fixed effects as given below in Figure 5.8.

Figure 5.8. Selection of categorical fixed effects

6. Select the continuous fixed effect: After selecting the categorical fixed effects,
the user can now select the continuous variable from the remaining variables, if
available. We have selected “Age” in the given example (Figure 5.9).
62

Figure 5.9. Selection of continuous variables

7. Select the random effects: After selecting the fixed effects, the user has to
select the random effects, if available. We have selected “Run” as random effect
as given below in Figure 5.10.

Figure 5.10. Selection of random effects

8. Select the categorical fixed effect of interest: The user has to specify the
variable of interest which is considered to be having a fixed effect. We have
selected “Group” as the variable under study (Figure 5.11).
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Figure 5.11. Selection of categorical fixed effect of interest

9. Select a comparison of interest: We selected “Control vs. Case1” from the list
of all available pairwise comparisons in the drop-down menu (Figure 5.12).
“Control vs. Case1” means “Case1” is compared to “Control”.

Figure 5.12. Selection comparison of interest

10. Choose method of analysis: We have provided two options for the analysis:
(i) Excluding missing values, and (ii) Imputing missing values (default option).
There are two methods of data imputation available: (a) SVD, and (b) KNN. We
selected the radio button “Imputing missing values” and “SVD” method for data
imputation. The screenshots are given below in Figure 5.13.

Figure 5.13. Select analysis method
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11. Choose the transformation and/or normalization methods : There are four
options

available

(log2/QN/VSN/None).

for

data

transformation

We

selected

“Quantile

and/or

normalization

Normalization”

for

data

normalization as given below.

Figure 5.14. Selection of normalization method

12. Method of DE analysis: We provide: (i) LIMMA/ Moderated t-test, (ii) linear
fixed or mixed model approach, and (iii) various forms of t-test: The LIMMA
method provides the most reliable and robust statistical test. Therefore, we have
made this option as the default method. On clicking the radio button “T-test”, a
dropdown menu showing three different types of t-test will appear as given below
in Figure 5.15.

Figure 5.15. Selection of statistical testing method

We have selected the default method (LIMMA/Moderated t-test) for the
demonstration.
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13. Select the significance level: The user has to specify the level of significance.
We have selected the default value 0.05 as the significance level (Figure 5.16).

Figure 5.16. Specify the level of significance

14. Desired log2 fold change (FC) cut-off: The user can specify a desired log2 FC
cut-off. We have specified the default value of log2 FC as 1 (Figure 5.17).

Figure 5.17. Specify the desired log fold change

15. Method of adjustment: The user has to select the method of adjusting the pvalues for multiple testing of features. We have provided six adjustment methods.
We selected “BH” adjustment method (Figure 5.18).

Figure 5.18. Specify the adjustment method

Output specifications
After specifying all the inputs, the user has to hit the “Submit” button and wait for
the results. The results are displayed by clicking on the respective tabs. The
screenshots for all the results are as follows.
1. Inputs selected: The various inputs defined by the user for the analysis can be
viewed under the tab “Inputs selected” as given in Figure 5.19.
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Figure 5.19. Inputs selected

2. Visual plots of the preprocessed data: Various exploratory plots of the
preprocessed data such as box plots, density plots, correlation heatmap and
MDS plot can be viewed under their respective tabs as shown in Figures 5.205.23.

Figure 5.20. Box plots of preprocessed expression data for different groups
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Figure 5.21. Density plots of preprocessed expression data for different groups

Figure 5.22. Interactive correlation heatmap of preprocessed expression data

Figure 5.23. Interactive MDS plot
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3. Differential expression analysis results: Summary of results showing the total
number of features (proteins or peptides) analyzed, number of differentially
expressed features, number of differentially expressed features between desired
log FC cutoffs, number of upregulated and downregulated features will be
obtained under “Summary” tab. The summary will be for both adjusted and not
adjusted. An example is shown below in Figure 5.24.

Figure 5.24. Summary of result

The result of DE analysis of the features can be viewed under the tab
“Table of DE features” (Figure 5.25). It will show the result for each feature
analyzed. We have analyzed the data at “Protein” level using the SVD imputation
method. Therefore, the table shows the names of proteins in first column and the
number of peptides belonging to a protein in second column. If the data are
analyzed at the “Peptide” level, then the first column contains the protein names
and the second column contains the peptide sequence. The table also shows the
percent of MVs in each group, e.g., “MV (%) Control” and “MV (%) Case1”’. If the
user chooses the method excluding MVs, then the percent of MVs will not
appear. The table also shows the estimate (equivalent to log2 FC), t-value,
degree of freedom (df), p-values without adjustment and adjusted p-values for
each feature. The user can download the results by clicking on the download link
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button. The table of differentially expressed features, complete results and
preprocessed data will be downloaded in zip format. If more than two groups are
present, then the complete results will have overall F-value, F statistic (without
and with adjustment), DE analysis results based on all pairwise contrast or
comparison.

Figure 5.25. Result of differential expression analysis

The interactive volcano plots without adjustment and with adjustment can be
viewed respectively under the tabs “Volcano plot (Not adjusted)” and “Volcano
plot (Adjusted)” (Figures 5.26 and 5.27).

Figure 5.26. Volcano plot without adjustment
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Figure 5.27. Volcano plot with adjustment

All the results can be downloaded by clicking on the download link button
provided under each tab. The table results will be download in xlsx format. The
visual plots will be download in png format. Some results will be download in zip
format. The user has to unzip the files and the individual files in xlsx or png
format can be viewed separately.
Here, we analyzed the data at protein level. We used the mean of
expression values of peptides corresponding to a protein. We compared the
groups “Control vs. Case1” for differential expression analysis. We adjusted the
effect due to race (categorical) and age (continuous). The run effect is
considered as the variable having random effect. We normalize the data using
QN and imputed the data using “SVD” method. We used the LIMMA method with
desired log2 FC 1 at the significance level 0.05. We used the “BH” method for
adjusting multiple testing of proteins. The distribution of the expression data of
different samples in each group can be examined by exploratory plots such as
box plots (Figure 5.20) and density plots (Figure 5.21). The interactive correlation
heatmap (Figure 5.22) shows the correlation coefficients and p-values of
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correlation for all possible pair of samples. The MDS plot allows the user to find
the relationship among the samples based on the group. In Figure 5.23, the
samples are clustered well together in each group except for one sample in
“Case1” group. The summary of DE analysis is given in Figure 5.24. The number
of differentially expressed proteins without adjustment is 67 out of total 200
proteins. Without adjustment, there are 16 upregulated and 20 downregulated
proteins at log2 FC cut-off of ±1; and 31 significant proteins between the log2 FC
cut-offs. However, the p-values need to be adjusted for testing the multiple
proteins. Therefore, with adjustment, we found only 39 proteins to be significant
(14 upregulated, 15 downregulated and 10 significant between the log2 FC cutoffs). The result of DE analysis for each protein can be viewed and a portion of
the result is given in Figure 5.25. The volcano plot is generally used to display
the result of DE analysis. The interactive volcano plots without and with
adjustment are given in Figure 5.26 and 5.27 respectively. The most upregulated
proteins are towards the right (red color) and the most downregulated proteins
are towards the left (blue color) with the most statistically significant proteins are
towards the top (above the dotted horizontal line). The non-significant proteins
are towards the down (black color). The plot also displays the significant proteins
between the log FC cut-offs (green color). All the results can be viewed and
downloaded.

Discussion
Our tool is a valuable source for analyzing proteomics expression data even in
the presence of MVs and accommodating complex experimental design. We
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have fully tested our tool for proper function. The user can perform the analysis
interactively and can download the results for each comparison. In case of more
than two groups, the user can download the complete results with DE analysis
results for all possible pairwise comparisons. We compared our tool “SATP” with
the existing tools, RepExplore [57] and MSqRob [79] for the DE analysis of
proteomics expression data. A brief comparison among the tools is given below:
Table 5.1. Comparison among the tools: SATP, RepExplore and MSqRob
SATP

RepExplore MSqRob

Ability to handle MVs

Yes

No

No

Ability to compare more than two groups

Yes

No

Yes

Ability to adjust additional covariates

Yes

No

No

As compared to the existing tools, our tool has several advantages. The first
advantage is that the tool can analyze data having missing observations while
considering the heterogeneity due to biological and technical replicates. We also
provide the percentage of MVs for each feature for various groups under
comparison in the results obtained using imputation method. This will be helpful
for deciding whether the feature is significant or not. The second advantage is
that we have provided robust statistical methods such as LIMMA and linear
fixed/mixed models that can accommodate complex experimental design. The
user can also control the effects of additional covariates such as gender, age,
height, etc. Our tool can analyze the data for two or more than two groups. The
third advantage is the user can analyze the data both at the protein and peptide
levels.
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Conclusion
Our tool will be a useful resource for the researches working in the field of
proteomics and bioinformatics. We have provided different ways to analyze
proteomics abundance data. Furthermore, this can be used to analyze data from
similar experiments with expression values (e.g., microarray and metabolomics
data).
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CHAPTER 6
SAMPLE

SIZE

ESTIMATION

FOR

HETEROGENEOUS

PROTEOMICS

EXPERIMENTS USING STATISTICAL AND COMPUTATIONAL APPROACHES

Introduction
Proteomics studies are carried out on large scale and designed to address both
qualitative and quantitative aspects of the proteome [11, 12]. The proteomics
experiment can lead to identification of novel biomarkers which are measurable
indicator of some biological state or condition [87]. The biomarker discovery will
lead to better understanding of the biological or physiological process such as
mechanism of disease. Despite the major advances in proteomics and
bioinformatics approaches, still there are limitations and challenges in the
experimental design.
Design and sample size estimation are important for carrying out
proteomics experiments. Various studies have been done with respect to the
design, power analysis and sample size calculation for proteomics experiments
[51, 88-91]. The sample size required in a study depends on various constraints
such as data availability, budget, support facilities, time requirement, etc. Sample
size can be estimated by either using simulation methods or using pilot data or
using similar data sets. However, the proteomics data obtained from proteomics
experiments have a lot of missing values (MVs) and are highly heterogeneous. In
previous chapters, we have suggested the use of the imputation methods for
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better analysis of proteomics experiments. In this chapter, we have provided
various statistical approaches for sample size calculation.
In Chapter 5, we have developed a tool for differential expression analysis
of proteomics experiment. In this chapter, we developed sample size calculation
methods to test the significance of features for quantitative proteomics
expression data. Sample size calculation for testing the significance of features
between two groups is based on Welch’s t-test [92, 93]. We have implemented
all the methods in R [1] and we have developed user-friendly shiny apps [3] for
estimating sample size for proteomics experiment under allocation and cost
constraints.
In Chapters 3 and 4, we studied and implemented various approaches of
standardizing proteomics workflow for LC-MS data. In the last section of this
chapter, we studied the impact of technical variability on the study design for
proteomics experiment. The sample size calculation is based on the coefficient of
variation (CV) [94].
Sample size calculation for detecting differentially expressed features
between two classes
The sample size and cost estimation are important for carrying out the
experiments successfully. Our method of sample size calculation is based on
Welch’s t-test for comparing means between two groups (or classes) [92]. We
have used the general methods of optimal sample sizes for Welch’s test given by
Jan and Shieh [93]. The methods were modified and extended to estimate
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sample size for proteomics experiment involving multiple features. These
methods are discussed below:
A. Sample size calculation for comparing means between two groups for a
single feature
The study aims at class comparison, that is, detecting features which significantly
differ in abundance between two groups. We construct the hypothesis setting for
testing group effect, i.e., whether a feature is differentially expressed between
two groups, as given below:
𝐻0 : 𝜇1 = 𝜇2 vs. 𝐻1 : 𝜇1 ≠ 𝜇2
where, 𝜇1 and 𝜇2 are the population means corresponding to group 1 and group
2 respectively.
Alternatively, the above setting can be written as
𝐻0 : 𝜇𝑑 = 0 vs. 𝐻1 : 𝜇𝑑 ≠ 0
where, 𝜇𝑑 = 𝜇1 − 𝜇2 = 0.
The outcomes of testing the null hypothesis belong to one of the four scenarios
as given below in Table 6.1.
Table 6.1. The outcomes of testing null hypothesis vs. alternative hypothesis

null hypothesis

Decision about

Null hypothesis (equal abundance)
True equal abundance

False equal abundance

Correct decision (1 − 𝛼)

Type II error (𝛽)

(abundances are equal)

True Negative

False Negative

Reject (abundances are

Type I error (𝛼)

Correct decision (1 − 𝛽)

False Positive

True Positive

Fail to reject

unequal)

77

The significance level of test 𝛼 is the probability of making type I error. The
probability of type II error is denoted as 𝛽. The power of the test, (1 − 𝛽), is
defined as the probability of correctly rejecting the false null hypothesis. We need
to fix the significance level and power of the test at desired levels in advance.
Furthermore, we must specify the desired fold change (FC) or difference
between population means to be detected.
Two-sample t-test is derived under the assumptions that the populations
are normally distributed and have equal variance. The Welch’s t-test is an
adaptation of Student’s t-test and is more robust when the populations have
unequal variance, and/or the sample sizes are unequal. Let us consider
independent random samples from two normal populations, 𝑋𝑖𝑗 ~𝑁(𝜇𝑖 , 𝜎𝑖2 ),
(𝑖 = 1, 2; 𝑗 = 1, 2, … , 𝑁𝑖 ) where 𝜇1 , 𝜇2 , 𝜎12 and 𝜎22 are unknown parameters. The
Welch’s test statistic is defined as
𝑡𝑊 =

𝑁

where 𝑋̅𝑖 =

𝑖 𝑋
∑𝑗=1
𝑖𝑗

𝑁𝑖

𝑋̅1 −𝑋̅2
𝑆2 𝑆2
√ 1+ 2
𝑁1 𝑁2

𝑁

and

𝑆𝑖2

=

𝑖 (𝑋 −𝑋
∑𝑗=1
𝑖𝑗 ̅ 𝑖 )

(𝑁𝑖 −1)

(6.1)

2

.

Under null hypothesis 𝐻0 , the approximate distribution of 𝑡𝑊 given by Welch [92]
is 𝑡𝑊 ~𝑡(𝑛̂), i.e., t with 𝑛̂ degrees of freedom given by
2

2 2

𝑆
𝑆
( 1+ 2)

𝑛̂ =

𝑁1 𝑁2

𝑆4
1

𝑆4
+ 2 2
2
𝑁1 (𝑁1 −1) 𝑁2 (𝑁2 −1)

(6.2)

The null hypothesis is rejected if |𝑡𝑊 | > 𝑡𝑛̂,𝛼⁄2 , where 𝑡𝑛̂,𝛼⁄2 is the upper 100(𝛼/
2)th percentile of the t-distribution 𝑡(𝑛̂). The same concept was also suggested
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by Smith [95] and Satterthwaite [96]. Therefore, the test is also sometimes
referred to as the Smith-Welch-Satterthwaite test. The test is an approximate
solution of Behrens-Fisher problem. The exact distribution of Welch’s t-test is
complicated, and it can be expressed in different forms. We use the following
notations for the alternate expression of Welch’s t-test [93].
𝑍=

𝑋̅1 − 𝑋̅2
~𝑁(𝛿, 1)
𝜎
𝛿=

𝜇1 − 𝜇2
𝜎

𝜎12 𝜎22
𝜎 =
+
𝑁1 𝑁2
2

𝑊=

(𝑁1 − 1)𝑆12 (𝑁2 − 1)𝑆22
+
~𝜒 2 (𝑁1 + 𝑁2 − 2)
𝜎12
𝜎22

(𝑁1 − 1)𝑆12
(𝑁1 − 1) (𝑁2 − 1)
𝜎12
𝐵=
~𝐵𝑒𝑡𝑎 (
,
)
𝑊
2
2
The alternate expression of Welch’s test statistic is given by
𝑡𝑊 =
where 𝑇 =

𝑍

𝑇
√𝐻

(6.3)

~𝑡(𝑁1 + 𝑁2 − 2, 𝛿), which is the non-central t-distribution with

𝑊

√𝑁 +𝑁 −2
1
2

𝜎2 𝐵

degrees of freedom 𝑁1 + 𝑁2 − 2 and non-centrality parameter 𝛿; 𝐻 = 𝑁1 𝑝 +
1

𝜎22 (1−𝐵)
𝑁2 (1−𝑝)

with 𝑝 = 𝑁

𝑁1 −1

. The random variables, Z, W and B are mutually

1 +𝑁2 −2

independent. Here, the variables T and B are also independent. The alternate
expression of degrees of freedom can be written as
𝑛̂ =

1

(6.4)

2
𝐵2
1 + 𝐵2
(𝑁1 −1) (𝑁2 −1)
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where, 𝐵1 =

𝜎2
1𝐵
𝑁1 𝑝
2
𝜎2
1 𝐵+ 𝜎2 (1−𝐵)
𝑁1 𝑝 𝑁2 (1−𝑝)

and 𝐵2 = 1 − 𝐵1. The power function of 𝑡𝑊 is given by

𝜋(𝜇𝑑 , 𝜎12 , 𝜎22 , 𝑁1 , 𝑁2 ) = 𝑃{|𝑡𝑊 | > 𝑡𝑛̂,𝛼⁄2 } = 𝑃{|𝑇| > 𝑡𝑛̂,𝛼⁄2 √𝐻}

(6.5)

The exact power can be calculated by using Simpson’s rule.
A1. Allocation of samples between two groups
𝑁

Let the sample size ratio (𝑁2 = 𝑟 ≥ 1) between two groups be fixed in advance.
1

Then the power function becomes a strictly monotone function of 𝑁1 with other
parameters held constant. A simple incremental search can be used to find out
the minimum sample size 𝑁1 required to achieve the given power at a
significance level 𝛼. The large sample normal approximation can be used as the
starting values for the iteration. According to Jan and Shieh [93], the starting
sample size 𝑁1𝑍 would be the smallest integer satisfying the inequality
2

𝑁1𝑍 = (𝜎12 + 𝜎22 ⁄𝑟)(𝑧𝛼/2 + 𝑧𝛽 ) ⁄𝜇𝑑2

(6.6)

However, for large values of 𝜇𝑑 , the program sometimes return error as the
starting value of 𝑁1𝑍 is less than 1. Therefore, we are using max(𝑁1𝑍 − 1, 1) as
the starting value. For example, if we use the original program with 𝜇𝑑 = 4, it will
not return any result. With the input parameters given below, we found the
following sample sizes with the actual power achieved. The original program was
unable to calculate the sample sizes with parameters 𝜇𝑑 = 4, 𝛼 = 0.05, 1 − 𝛽 =
0.90 for different values of r and 𝜎1 : 𝜎2 . The sample sizes and the exact power
obtained with these parameters are shown in Table 6.2.
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Table 6.2. Sample sizes (𝑁1 , 𝑁2 ) and power computed when r is fixed with parameters
𝜇𝑑 = 4, 𝛼 = 0.05, 1 − 𝛽 = 0.90 for different combinations of r and 𝜎1 : 𝜎2 .
𝝈𝟏 : 𝝈𝟐
1/3:1

1/2:1

1:1

2:1

3:1

r

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

1

3

3

0.9245

3

3

0.9330

4

4

0.9926

6

6

0.9590

9

9

0.9235

2

2

4

0.9876

2

4

0.9313

3

6

0.9479

5

10

0.9077

9

18

0.9307

3

2

6

0.9907

2

6

0.9307

3

9

0.9443

5

15

0.909

9

27

0.9328

A2. Allocation of samples between two groups under a budget constraint
The various costs incurred for conducting a proteomics experiment such as
quantitative LC-MS/MS are as follows:
(i) Sample procurement cost: It depends on the number biological and/ or
technical replicates for each condition. For a case-control study, with 𝑁1 and 𝑁2
replicates respectively, in control and case groups, the cost will be 𝑐1 = 𝑎11 𝑁1 +
𝑎12 𝑁2 , where 𝑎11 and 𝑎12 are respectively the sample procurement cost per
sample in control and case.
(ii) Sample preparation cost: It involves the methods such as digestion (e.g.
trypsin), alkylation, µ-Solid Phase Extraction and sample cleaning. The cost will
be 𝑐2 = 𝑎2 (𝑁1 + 𝑁2 ), where 𝑎2 is the sample preparation cost per sample.
(iii) LC-MS/ MS analysis: The cost of LC-MS/MS analysis will depend on the type
of sample (e.g., simple or complex) and duration. The cost for LC-MS/MS
analysis will be 𝑐3 = 𝑎3 (𝑁1 + 𝑁2 ), where 𝑎3 is per sample LC-MS/MS analysis
cost.
(iv) Database search and protein identification: 𝑐4 = 𝑎4 (𝑁1 + 𝑁2 ), where 𝑎4 is the
cost for database search and identification.
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(v) Analysis: 𝑐5 = 𝑎5 (𝑁1 + 𝑁2 ), where 𝑎5 is the average cost of analysis per
sample.
The total cost for conducting the experiment is given by
𝐶 = 𝑐1 + 𝑐2 + 𝑐3 + 𝑐4 + 𝑐5
= (𝑎11 + 𝑎2 + 𝑎3 + 𝑎4 + 𝑎5 )𝑁1 + (𝑎12 + 𝑎2 + 𝑎3 + 𝑎4 + 𝑎5 )𝑁2
Therefore, the total cost can be written as 𝐶 = 𝐶1 𝑁1 + 𝐶2 𝑁2 , where 𝐶1 and 𝐶2 are
the average cost per sample in control and case, respectively. The list of prices
for each step are available at various online sources. A hypothetical example of
cost calculation per sample in a quantitative proteomics experiment is given
below in Table 6.3.
Table 6.3. A hypothetical example of various costs involved in quantitative proteomics
experiment
Services

Price per sample (in USD)

Sample procurement cost
Sample
cleanup

preparation:

50

digestion,

extraction

and

60

LC-MS/MS

100

Data base search and protein identification

50

Analysis

40

Total cost per sample

300

Let the total cost 𝐶 is fixed in advance as given below:
𝐶 = 𝐶1 𝑁1 + 𝐶2 𝑁2
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(6.7)

The optimal sample size ratio is proportional to the ratio of standard deviations
divided by the square root of ratio of costs [97]. Therefore, the optimal allocation
is obtained when the ratio of sample sizes assumes the equality
𝑁2
𝑁1

1/2

=

𝜎2 𝐶1

1/2

𝜎1 𝐶2

=𝜃

(6.8)

A2.1. Sample allocation with maximum power under a fixed cost
When the total cost is fixed, then the maximum power is obtained using the
sample size combination given below:
1/2

𝑁1𝑍 =

𝐶(𝜎1 𝐶2

)

1/2
1/2
𝐶1 (𝜎1 𝐶2 )+𝑐2 (𝜎2 𝐶1 )
1/2

𝑁2𝑍 =

𝐶(𝜎2 𝐶1

)

1/2
1/2
𝐶1 (𝜎1 𝐶2 )+𝐶2 (𝜎2 𝐶1 )

(6.9)

(6.10)

We calculate the power for various combinations of 𝑁1 and 𝑁2 and find the
optimal allocation, that is, the combination giving the maximum power. We vary
the value of 𝑁1 from 𝑁1𝑀𝑖𝑛 to 𝑁1𝑀𝑎𝑥 , where 𝑁1𝑀𝑖𝑛 = 𝑓𝑙𝑜𝑜𝑟(𝑁1𝑍 ) − 1 and 𝑁1𝑀𝑎𝑥 =
𝑐𝑒𝑖𝑙𝑖𝑛𝑔 [

𝐶−𝐶2 {𝑓𝑙𝑜𝑜𝑟(𝑁2𝑍 )−1}
𝑐1

]. The function floor(x) in R rounds to the nearest integer

that is smaller than x. The function ceiling(x) in R rounds to the nearest integer
that is larger than x. In their work, the value of 𝑁1𝑀𝑎𝑥 was rounded using floor
function. However, we found the maximum power is achieved on using ceiling
function. Also, we found that the number of samples required is less when the
ceiling function is used instead of floor function. For example, we estimate
sample sizes for a fixed cost 𝐶 as given below in Table 6.4. We found that our
method has more power for a given fixed cost with less number of samples as
compared to the original method.
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Table

6.4.

Sample

sizes

𝑁2 ),

(𝑁1 ,

total

number

of

samples

(𝑁1 + 𝑁2 ) and the power obtained for fixed cost C with parameters 𝜇𝑑 = 4, 𝛼 = 0.05,
𝐶1 : 𝐶2 = 1: 1/3 and different values of 𝜎1 : 𝜎2 using our method and the original method.
𝝈𝟏 : 𝝈𝟐
1/3:1

Our method
Original
method

1/2:1

𝑪𝟏 : 𝑪𝟐

C

𝑵𝟏

𝑵𝟐

𝑵𝟏 + 𝑵𝟐

Power

C

𝑵𝟏

𝑵𝟐

𝑵𝟏 + 𝑵𝟐

Power

1:1/3

25

10

45

55

0.999646

30

15

45

60

0.998665

1:1/3

25

9

48

57

0.999626

30

14

48

62

0.998663

A2.2. Sample allocation with minimum cost for a fixed power
When the power is fixed, then the minimum total cost can be obtained using the
sample size combination given below:
𝑁1𝑍 =
𝑁2𝑍 =

(𝜃𝜎12 +𝜎22 )(𝑧𝛼/2 +𝑧𝛽 )

2

(6.11)

2
𝜃𝜇𝑑

(𝜃𝜎12 +𝜎22 )(𝑧𝛼/2 +𝑧𝛽 )

2

(6.12)

2
𝜇𝑑

The optimal allocation is found by screening the different sample size
combinations and finding the combination that gives the minimum cost at the
desired power. We vary the value of 𝑁1 from 𝑁1𝑀𝑖𝑛 to 𝑁1𝑀𝑎𝑥 , where 𝑁1𝑀𝑖𝑛 =

𝑚𝑎𝑥{𝑓𝑙𝑜𝑜𝑟(𝑁1𝑍 ), 2} and 𝑁1𝑀𝑎𝑥 = 𝑚𝑎𝑥 {𝑐𝑒𝑖𝑙𝑖𝑛𝑔 [

𝜇2
𝑑

(𝑧𝛼/2 +𝑧𝛽)

𝜎12
2−

𝜎2
2
(𝑓𝑙𝑜𝑜𝑟(𝑁2𝑍 )−1)

] , 2}. We use

different form of 𝑁1𝑀𝑖𝑛 and 𝑁1𝑀𝑎𝑥 that differs from the original work. The minimum
and maximum value of 𝑁1 must be at least 2.
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B. Sample size calculation for comparing means between two groups for
multiple features
In proteomics experiments, the experimenter is interested in comparing the group
means for many features. Several multivariate generalizations of type I error and
power of the test exist along with several statistical techniques of their control.
Suppose we simultaneously test m null hypotheses (or compare the abundance
of m features) (H1, H2, ..., Hm). We reject the null hypothesis if the test is declared
significant. We do not reject the null hypothesis if the test is non-significant. Let
m0 features do not differ significantly between the two populations (number of
true null hypothesis). The various possible outcomes for testing multiple null
hypotheses are shown below in Table 6.5.
Table 6.5. The possible outcomes of testing multiple null hypotheses

Decision about
null
hypothesis

True state
Null/ Nonsignificant

Alternative/
Significant

Failed to reject null/
Declared nonsignificant

U
(TN)

T
(FN)

m-R

Rejected null/
Declared
significant

V
(FP)

S
(TP)

R

Total

m0

m1 = m - m0

m

We define the following terms based on Table 6.5:
m is the number of features/hypotheses tested.
m0 is the number of true null hypothesis (unknown parameter).
V is the number of false positives (type I error)/ false discoveries.
U is the number of true negatives.
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Total

T is the number of false negatives (type II error)
S is the number of true positives/ true discoveries.
R = V+S, the number of rejected null hypotheses/ discoveries.
S, T, U and V are unobservable random variables.
R is observable random variable.
False discovery rate (FDR) is considered as one of the most powerful
multivariate generalization of type I error. FDR-controlling procedures are
designed to control the expected proportion of false discoveries (incorrectly
rejected null hypotheses). Mathematically, FDR is defined as
𝑉

𝐹𝐷𝑅 = 𝐸 [max(𝑅,1)]

(6.13)

where 𝐸[. ] denotes the expected value. The Benjamini-Hochberg (BH) procedure
[98] can be used to calculate the number of replicates required for future
experiments with multiple features while controlling the FDR. In BH procedure,
we first arrange the p-values of the m comparisons from largest (least significant)
to smallest (most significant) values. Then, we compare p(j) with (j/m)*q. We
reject the null hypotheses if p(j) ≤ (j/m)*q. Let Rave be the average number of
rejections and (1 − 𝛽𝑎𝑣𝑒 ) be the average power. Then it follows that
𝑚𝛼𝑎𝑣𝑒 ≤ 𝑅𝑎𝑣𝑒 𝑞 ≅ [𝑚0 𝛼𝑎𝑣𝑒 + 𝑚1 (1 − 𝛽𝑎𝑣𝑒 )]𝑞

(6.14)

Thus, the BH procedure controls the average type I error over all the features at
𝛼𝑎𝑣𝑒 ≤

(1−𝛽𝑎𝑣𝑒 )𝑞

𝑚
1+(1−𝑞) 0

(6.15)

𝑚1

The procedure provides less stringent control of type I errors compared to
familywise error rate controlling procedures such as the Bonferroni correction.
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The sample size calculation methods for comparing group means using
Welch’s t-test were extended for multiple features. The users have to specify
extra input parameters, namely, FDR, average power (1 − 𝛽𝑎𝑣𝑒 ), number of
features (m) and expected number of differentially expressed features (m1).
Based on these extra input parameters, we compute the average type I error
(𝛼𝑎𝑣𝑒 ) for overall features. Then we replace the significance level 𝛼 and power
(1 − 𝛽) by 𝛼𝑎𝑣𝑒 and (1 − 𝛽𝑎𝑣𝑒 ), respectively in the formulae given in Section A.
The three options available for estimating sample size without using pilot data by
specifying only the input parameters are given below:
B1.1. Sample allocation with no cost constraint: Please see Section A1.1.
B2.1. Sample allocation with maximum power for a fixed cost: Please see
Section A2.1.
B2.2. Sample allocation with minimum cost for a fixed power: Please see Section
A2.2.
We have developed a shiny application for computing sample size under various
constraints as discussed in Sections A and B.
Sample size calculation using pilot data
We studied various ways to calculate sample size for detecting differentially
expressed features between two groups based on pilot data for conducting future
experiments. We used the data corresponding to first two groups as given in
previous chapter and estimated the sample sizes for detecting differentially
expressed proteins between two groups. We normalized the data first by taking
logarithmic base 2 followed by quantile normalization (QN). We used the singular
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value decomposition (SVD) method to impute the data. There are total 200
proteins (m = 200). We assumed the expected proportion of differentially
expressed proteins to be 0.10. We computed 𝛼𝑎𝑣𝑒 (= 0.0042) by assuming the
average power to be 0.80 and FDR (q) to be 0.05 . We estimated the standard
deviations (SDs), 𝜎̂1 and 𝜎̂2 in two groups for each feature from the data. Then,
we used the mean, median, 90th percentile value and maximum value of
estimated SDs for sample size calculation for each of the three options. Please
see Table 6.6 for summary of estimates of SDs for two groups.
Table 6.6. Summary of estimated standard deviations for two groups
𝝈
̂𝟏

𝝈
̂𝟐

Mean

0.52

0.59

Median

0.41

0.36

90th percentile

1.09

1.30

Maximum

2.27

3.64

The sample size calculation for each of the three options under various scenarios
are given below.
(i) Sample allocation with no cost constraint: We computed the sample size for
𝑁

𝑁

experiment with equal samples (𝑟 = 𝑁2 = 1) and unequal samples (𝑟 = 𝑁2 = 2).
1

1

The results are given in Table 6.7. For equal sample sizes, we found that it
requires minimum number of samples with maximum power using median values
of SDs. For unequal sample sizes, we found that it requires minimum number of
samples using median values of SDs whereas the maximum power is obtained
using mean values of SDs.
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Table

6.7.

Sample

sizes

𝑁2 ),

(𝑁1 ,

total

number

of

samples

(𝑁1 + 𝑁2 ) and the exact power obtained with log2 FC 1 for fixed sample size ratio (1 and
2).

𝑟=

𝑟=

𝑁2
=1
𝑁1

𝑁2
=2
𝑁1

𝑵𝟏

𝑵𝟐

𝑵𝟏 + 𝑵𝟐

Exact power

Mean

11

11

22

0.8160

Median

7

7

14

0.8463

90th percentile

42

42

84

0.8061

Maximum

256

256

512

0.8020

Mean

9

18

27

0.8622

Median

6

12

18

0.8187

90th percentile

30

60

90

0.8072

Maximum

163

326

489

0.8002

(ii) Sample allocation with maximum power for a fixed cost: We assumed the cost
(in USD) per sample in group 1 and 2 are 300 and 325, respectively. Then, we
estimated the sample sizes giving maximum power for conducting experiments
with the total budget of 5000, 10000 and 15000, respectively. The results are
shown below in Table 6.8. We found that maximum power with minimum number
of samples are obtained using median values of SDs for all the three fixed costs.
Table

6.8.

Sample

sizes

𝑁2 ),

(𝑁1 ,

total

number

of

samples

(𝑁1 + 𝑁2 ) and the maximum power obtained with log2 FC 1 for fixed cost (5000, 10000
and 15000)
𝑵𝟏

𝑵𝟐

𝑵𝟏 + 𝑵𝟐

Exact power

Mean

8

8

16

0.562

Median

8

8

16

0.9258

90th percentile

8

8

16

0.0697

Maximum

8

8

16

0.0106

𝑪 = 5000

89

Mean

16

16

32

0.9698

Median

17

15

32

1

90th percentile

16

16

32

0.2492

Maximum

12

19

31

0.0229

Mean

24

24

48

0.9991

Median

25

23

48

1

90th percentile

24

24

48

0.4571

Maximum

18

29

47

0.0391

𝑪 = 10000

𝑪 = 15000

(iii) Sample allocation with minimum cost for a fixed power: We assumed the cost
(in USD) per sample in group 1 and 2 are 300 and 325, respectively. We
calculated the minimum cost for conducting the experiment to achieve a
desirable power of 0.80. The results are shown below in Table 6.9
Table

6.9.

Sample

sizes

𝑁2 ),

(𝑁1 ,

total

number

of

samples

(𝑁1 + 𝑁2 ) and exact power obtained for a minimum cost of experiment with log 2 FC 1
𝑵𝟏

𝑵𝟐

𝑵𝟏 + 𝑵𝟐

Power

Minimum cost

Mean

11

11

22

0.8160

6875

Median

8

6

14

0.8376

4350

90th percentile

39

44

83

0.8040

26000

Maximum

191

293

484

0.8006

152525

Web app for calculating sample size using pilot data
We have developed a tool/app for calculating sample size for detecting
differentially expressed features between two groups based on pilot data for
conducting future experiments. We have provided various options of estimating
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sample size using pilot data. A screen shot of the app “SSCP: Sample Size
Calculator for Proteomics Experiment” is given below:

Figure 6.1. Screenshot of the tool “SSCP”

Various inputs to be provided by the user are as follows:
(1) Choose file to upload pilot data: A pilot dataset in matrix form with N
(N=N1+N2) subjects in columns and m features in rows. In proteomics
experiment, the proteomics expression data may have MVs. We normalize the
data first by taking logarithmic base 2 followed by quantile normalization. We use
SVD method to impute the data in case of data with missing values.
(2) Select feature type (“Protein” or “Peptide”): The calculation will be based on
detection of differentially expressed features either at protein or peptide level. We
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summarize/aggregate the expression data by taking mean of common or
redundant features.
(3) Choose file to upload additional information: The file contains the sample
names and the group/class names under comparison.
(4) The expected proportion of significant features (𝜋1 ): The user has to specify
the expected proportion of differentially expressed features. The default value is
0.10.
(5) The desired FDR (q): We use the procedure given in Equations 6.13-6.15 for
controlling the FDR. The default value of FDR is 0.05.
(6) The desired average power (1 − 𝛽𝑎𝑣𝑒 ): The average power is specified to
calculate the 𝛼𝑎𝑣𝑒 using Equation 6.15.
(7) Desirable log2 FC: We assumed that the normalized data (log2 transformation
followed by QN) is normally distributed.
(8) Choose the method of sample size calculation: We have provided three
options for calculating sample size: (i) Sample allocation with no cost constraint,
(ii) Sample allocation with maximum power for a fixed cost and (iii) Sample
allocation with minimum cost for a fixed power. The user has to define other input
parameters for selected method of sample size calculation. The user has to
specify the sample size ratio after selecting the first method. If the user selects
second method, then he has to specify cost per sample in group 1 and 2 as well
as the total cost of the experiment. On selecting the third method, the user has to
specify the cost per sample in group 1 and 2.
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Based on the various input parameters, the user will get two tables (inputs
selected and outputs obtained). Example of inputs provided by the user from
steps 1 to 3 is given below.

Figure 6.2. Uploading the two input files and selecting feature type and class name under
comparison

Now the user has to specify other input parameters (steps 4-7) as given below.

Figure 6.3. Specifying expected proportion of significant features, false discovery rate, average
power and log2 fold change

Now the user has to choose any one method of sample size calculation (Step 8).
The screenshot of example under each constraint are given in Figure 6.4.
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Figure 6.4. The input parameters under each method of sample size calculation

An example of inputs and outputs after submitting the job for sample allocation
with maximum power for a fixed cost of 5000 assuming the cost per sample in
group 1 and 2 to be 300 and 325, respectively is given below:

Figure 6.5. Example of inputs and output obtained for sample allocation with maximum power for
a fixed cost
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The results obtained are same as given in Table 6.6 (estimates of standard
deivations) and Table 6.8 (sample sizes for fixed cost of 5000). The user can use
the app for sample size calculation under various contraints using pilot data.
However, in some situations, it may take more time to compute the sample sizes.
In such situations, the user can run the R programs on high performance
computing facility to get the result.

Impact of technical components on the study design and sample size
estimation of LC-MS proteomics workflow
The purpose of the approaches given in Chapters 3 and 4 was to standardize
proteomics workflow and to study variability in proteomics expression data. This
will help in designing and conducting proteomics experiments. As discussed in
Chapter 3, we have two tissue storage methods (FFPE and FR) and three tissue
extraction methods (MAX, TX.MAX and SDS.MAX). We studied the technical
variability associated with proteomics expression data. In this section, we studied
the impact of technical variability on the study design using real dataset given in
Chapter 3. We estimated the sample size based on CV and % effect sizes [94].
Sample size formulation
Let us consider two normal populations with means 𝜇1 , 𝜇2 and variances 𝜎12 , 𝜎22 .
When the variances are known, then the sample size per group with significance
level α and power (1 − 𝛽) is given by
2

(𝑧1−𝛼/2 + 𝑧1−𝛽 ) 𝑣 2 (𝜇𝑟2 + 1)
𝑁=
(𝜇𝑟 − 1)2

95

where, 𝜇𝑟 =

𝜇1 𝜇 1

,

𝜇2 𝜎1

=

𝜇2
𝜎2

= 𝑣, 𝑧1−𝑝 is the 100(1-p)th percentile of standard normal

distribution. The above formula can be adjusted by FDR-controlling procedures
for testing the significance of multiple features.
Sample size estimation
We studied the effect of tissue storage methods (FFPE and FR) and tissue
extraction methods (MAX, TX.MAX and SDS.MAX) on sample size estimation.
For example, suppose the experimenter has used the FR method for tissue
storage and he wants to estimate sample size for two-class comparison. Then,
the formula given in previous section can be used to estimate sample size based
on CV and the percentage change in means.
We used variance stabilizing normalization (VSN) method for data
normalization and SVD method for data imputation. We estimated the sample
size using the median and maximum value of CV for two TSMs and three TEMs
as given in Table 3.3. of Chapter 3. We have provided the sample sizes
computed for all the technical approaches at different percent change between
means (𝜇𝑟 - fold difference in means) in Table 6.10. The sample sizes
corresponding to without adjustment and FDR-adjusted are separated by “/”.

96

Table 6.10. Computed sample sizes for different technical approaches
Using median value of CV
TSM

Using maximum value of CV

TEM

TSM

TEM

FR

FFPE

MAX

TX.MAX

SDS.MAX

FR

FFPE

MAX

TX.MAX

SDS.MAX

1.05

66/ 78

6/ 8

13/ 15

13/ 15

72/ 85

445/ 524

246/ 290

339/ 400

306/ 361

461/ 543

1.1

18/ 21

2/ 2

4/ 4

4/ 4

19/ 23

117/ 138

65/ 77

90/ 105

81/ 95

122/ 143

1.15

9/ 10

1/ 1

2/ 2

2/ 2

9/ 11

55/ 65

31/ 36

42/ 49

38/ 45

57/ 67

1.2

5/ 6

1/ 1

1/ 2

1/ 2

6/ 7

33/ 38

18/ 21

25/ 29

23/ 27

34/ 40

1.25

4/ 4

1/ 1

1/ 1

1/ 1

4/ 5

22/ 26

12/ 15

17/ 20

15/ 18

23/ 27

1.3

3/ 3

1/ 1

1/ 1

1/ 1

3/ 3

16/ 19

9/ 11

13/ 15

11/ 13

17/ 20

1.35

2/ 3

1/ 1

1/ 1

1/ 1

2/ 3

13/ 15

7/ 8

10/ 11

9/ 10

13/ 15

1.4

2/ 2

1/ 1

1/ 1

1/ 1

2/ 2

10/ 12

6/ 7

8/ 9

7/ 8

11/ 12

1.45

2/ 2

1/ 1

1/ 1

1/ 1

2/ 2

9/ 10

5/ 6

7/ 8

6/ 7

9/ 10

1.5

2/ 2

1/ 1

1/ 1

1/ 1

2/ 2

7/ 9

4/ 5

6/ 7

5/ 6

8/ 9

1.75

1/ 1

1/ 1

1/ 1

1/ 1

1/ 1

4/ 5

3/ 3

3/ 4

3/ 4

4/ 5

2

1/ 1

1/ 1

1/ 1

1/ 1

1/ 1

3/ 4

2/ 2

3/ 3

2/ 3

3/ 4

2.5

1/ 1

1/ 1

1/ 1

1/ 1

1/ 1

2/ 3

1/ 2

2/ 2

2/ 2

2/ 3

3

1/ 1

1/ 1

1/ 1

1/ 1

1/ 1

2/ 2

1/ 1

2/ 2

1/ 2

2/ 2

The FR TSM requires more sample as compared to FFPE TSM. In TEM, the
SDS.MAX method requires more number of samples as compared to those of
MAX and TX.MAX. The sample size estimated is more when adjusting for
multiple proteins. The sample size with value 1 should be ignored. Here, we have
considered only the technical variability for sample size estimation. We have not
considered the biological variability. The sample size estimated will be much
more on inclusion of biological variability.

97

CHAPTER 7
SAMPLE SIZE CALCULATION FOR RNA-SEQ EXPERIMENTS CONSIDERING
HETEROGENEITY

Introduction
RNA-Seq has become the standard for measuring gene expression levels in
biological experiments. It differs from the microarray technology in various
aspects such as nature of data, normalization methods, differential expression
analysis methods, sensitivity, accuracy, etc. [99-101]. The RNA-Seq method is
developing rapidly and the cost of sequencing is declining. So, in the coming
future, more samples will be sequenced, and more experiments will be
performed. But still the cost per sample is the limiting factor in most of the
laboratories. There are two important points to be considered while designing
RNA-Seq experiments which are namely, the sequencing depth and the number
of replicates (biological and technical) required to observe significant changes in
expression. The other points should also be considered such as length of
transcripts, GC content and sequencing bias (influencing counts of transcripts
within a sample). The cost can be reduced by optimizing the designing process
of these experiments.
Various tools and software have been developed to address the problem
of sample size estimation and power analysis. Some of the examples are
RNASeqPowerCalculator [102], RNASeqPower [103], Scotty [104], PROPER
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[105], etc. The RNA-seq experiments are complex in nature, and still there is
requirement of advanced method to calculate sample size for differential
expression analysis using RNA-Seq data. In spite of various developments, this
field still lacks a general approach to estimate optimal sample size and power for
complex RNA-Seq experiments under the assumptions of various distributions.
There are various issues with the read counts for sample size and power
calculation such as over dispersion parameter estimation, excess zeros,
complexity of model, etc. The results obtained using the various methods for
differential expression analysis of RNA-Seq data from single organism or from
various sources of RNA-Seq data, do not lead to a common conclusion and
sometimes the results are not meaningful [106]. The misleading results are
caused due to heterogeneity issues at each step of RNA-Seq experiments.
Therefore, it is imperative to devise a statistical procedure for optimizing the
sample size calculation with reasonable statistical power and cost required for
conducting the experiments in the presence of heterogeneity. Therefore, we have
developed the statistical approaches for designing and sample size calculation
required to carry out the RNA-Seq experiments in the presence of heterogeneity
under the assumptions of various models.

Modeling the count data in RNA-Seq experiments
The RNA-Seq data is comprised mainly of the mapped read counts. The
counting of feature can be done at various levels such as gene level, transcript
level, exon level, etc. Instead of raw counts, normalized read counts such as
RPKM (reads aligned per kilobase of exon per million reads mapped) [107],
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FPKM (fragments per kilobase of exon per million fragments mapped), TPM
(transcripts per kilobase million), etc. are also used. However, from the statistical
point of view, actual counts are used as input for differential expression analysis
in many cases [108, 109]. As the raw count data are discrete in nature, therefore,
cannot be necessarily approximated well by normal (Gaussian) distributions,
therefore, the use of standard linear models like t-tests, ANOVA, regression
should not be preferred as the modeling framework. There are two popular
distributions for modelling the read counts which are given below:
(i) Poisson distribution [99, 110-113]: Let Y ~ Poisson (𝜆) be a random variable
representing the read counts for a gene in a sample, then its probability mass
function is given by
𝑝(𝑌 = 𝑦) =

𝑒 −𝜆 𝜆𝑦
𝑦!

,

𝑦 = 0, 1, 2, …

(7.1)

where 𝜆 is the rate parameter, i.e., expected number of reads per sample. The
mean and variance are equal to 𝜆. When 𝜆 is small, the data is over-dispersed,
i.e., there is more variation that expected under Poisson (𝜆). Similarly, when 𝜆 is
large, there is less variation than expected under Poisson (𝜆). Therefore, in most
of the cases, the RNA-Seq data is not modeled well by Poisson distribution as
the relationships between means and variances tend to be far more complicated
among (and within) biological replicates. The Poisson distribution accounts only
for the technical replicates. It is not well suited to account for the biological
replicates due to the problem of over dispersion caused by biological variations.
Various other forms of Poisson distribution such as Quasi-Poisson have been
developed to account for it with count data.
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(ii) Negative Binomial (NB) distribution [108, 109, 114-116]: The NB distribution is
assumed to be the natural distribution for modelling the read counts. If a random
variable Y has NB distribution with mean parameter 𝜇 and dispersion parameter
𝜙, then its probability mass function is given by
𝑝(𝑌 = 𝑦) =

1
𝜙

𝛤(𝑦+ )

(𝜇𝜙)𝑦

1
1
𝑦+
𝛤( )𝛤(𝑦+1)
𝜙
(1+𝜇𝜙) 𝜙

; 𝑦 = 0, 1, 2, …

(7.2)

with expected number of counts = 𝐸(𝑌) = 𝜇 and 𝑉𝑎𝑟(𝑌) = 𝜇 + 𝜙𝜇 2 . Here, the
dispersion parameter, 𝜙 is a measure of extra variance of Y that the Poisson
distribution does not account.
The regulation of gene expression can be studied across different
conditions such as levels of different factors, genotypes, environmental
conditions, developmental stages, etc. The major goal of RNA-Seq experiments
is to determine which features (e.g., genes, transcripts) show significant changes
in abundance across different condition or treatment. For differential expression
analysis, Y can be considered as the number of reads mapped to a reference
genome (read counts) that is generally modelled by assuming Poisson
distribution or NB distribution. Let us consider an RNA-Seq experiment including
a total of N samples. The samples are sequenced and resulting reads are
aligned with a reference genome. The numbers of reads mapped to each of the
reference gene are calculated.
Let us consider a study in which there are 𝐼 conditions/groups denoted by
𝐺𝑖 (𝑖 = 1, 2, … , 𝐼) and there are 𝑁𝑖 samples denoted by 𝑆𝑖,𝑗 (𝑗 = 1, 2, … 𝑁𝑖 )
corresponding to group 𝐺𝑖 . Now suppose, there are 𝐾 genes/features denoted by
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𝐹𝑘 (𝑘 = 1, 2, … , 𝐾) (Please see Table 2.1 in Chapter 2). Let 𝑦𝑖,𝑗,𝑘 be the number of
read counts corresponding to sample 𝑆𝑖,𝑗 (𝑖 = 1, 2, … , 𝐼; 𝑗 = 1, 2, … 𝑁𝑖 ) of group
𝐺𝑖 (𝑖 = 1, 2, … , 𝐼) for gene/feature 𝐹𝑘 (𝑘 = 1, 2, … , 𝐾). Total number of samples in
the study is 𝑁 = ∑𝐼𝑖=1 𝑁𝑖 . The library size/sequencing depth for the jth sample of
group 𝐺𝑖 is denoted by 𝐿𝑖𝑗 = ∑𝐾
𝑘=1 𝑦𝑖𝑗𝑘 which varies for each sample.
Normalization techniques are used to account for the within library and between
library variability. The normalized count data can be modelled by Poisson
distribution or NB distribution.

Estimation of parameters based on negative binomial distribution
Let for any feature 𝐹𝑘 , the observations 𝑌𝑖𝑗𝑘 are independently and identically
distributed as
𝑌𝑖𝑗𝑘 ~ 𝑁𝐵(𝑠𝑖𝑗𝑘 𝜇𝑖𝑘 , 𝜙𝑖𝑘 )
where 𝜇𝑖𝑘 and 𝜙𝑖𝑘 are the true expression level and dispersion parameter,
respectively for the feature 𝐹𝑘 in group 𝐺𝑖 , respectively; 𝑠𝑖𝑗 is the scaling/size
factor to normalize the raw read counts corresponding to the jth sample in ith
group. There are 𝑁𝑖 observations in group 𝐺𝑖 for each feature. The total number
𝑁

𝑖
of reads in the ith group for feature 𝐹𝑘 is 𝑌𝑖𝑘 = ∑𝑗=1
𝑌𝑖𝑗𝑘 . For simplicity, we

suppressed the notation for feature 𝐹𝑘 in the subscript of previous terms.
The estimation of parameters is an essential step for design and sample
size calculation. The parameter estimation can be done by using various
methods such as method of moments estimation (MME) [117], maximum
likelihood estimation (MLE) [118-120], maximum quasi-likelihood estimation
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(MQLE) [121]. The MME has certain limitations (when variance equals mean,
dispersion parameter equals infinity; when variance is less than mean, dispersion
parameter is negative; when variance-mean is small, dispersion parameter is
very large). The MLE methods tend to underestimate the dispersion parameters.
Besides these methods, there are various methods/models for estimation of
parameters such as pseudo-likelihood [122, 123], quasi-likelihood [124],
conditional maximum likelihood (CML) [125], conditional inference [126],
quantile-adjusted CML [114], conditional weighted likelihood [109].
Estimation of parameters without scaling factor: Let 𝑌𝑖𝑗 be a NB random
variable with mean 𝜇𝑖 and dispersion parameter 𝜙𝑖 , i.e., 𝑌𝑖𝑗 ~𝑁𝐵(𝜇𝑖 , 𝜙𝑖 ), then its
probability mass function is given by

𝑝(𝑌𝑖𝑗 = 𝑦𝑖𝑗 ) =

𝛤(𝑦𝑖𝑗 +

1
)
𝜙𝑖

𝑦
(𝜇𝑖 𝜙𝑖 ) 𝑖𝑗

1
1
)𝛤(𝑦𝑖𝑗 +1) (1+𝜇 )𝑦𝑖𝑗+𝜙𝑖
𝜙𝑖
𝑖 𝜙𝑖

𝛤(

; 𝑦𝑖𝑗 = 0, 1, 2, …

(7.3)

Then, the likelihood function is given by

𝐿(𝜇𝑖 , 𝜙𝑖 |𝑦𝑖𝑗 ; 𝑗 = 1, 2, … , 𝑁𝑖 ) =

𝑖
∏𝑁
𝑗=1

𝛤(𝑦𝑖𝑗 +

1
)
𝜙𝑖

𝑦
(𝜇𝑖 𝜙𝑖 ) 𝑖𝑗
1
1
𝛤( )𝛤(𝑦𝑖𝑗 +1) (1+𝜇 )𝑦𝑖𝑗+𝜙𝑖
𝜙𝑖
𝑖 𝜙𝑖

(7.4)

The log-likelihood function is given by
𝑁𝑖

𝑁𝑖

𝑁𝑖

𝑗=1

𝑗=1

𝑗=1

1
1
𝑙(𝜇𝑖 , 𝜙𝑖 |𝑦𝑖𝑗 ; 𝑗 = 1, 2, … , 𝑁𝑖 ) = ∑ ln 𝛤 (𝑦𝑖𝑗 + ) − ∑ 𝛤 ( ) − ∑ ln 𝛤(𝑦𝑖𝑗 + 1)
𝜙𝑖
𝜙𝑖
𝑁

𝑁

1

𝑖
𝑖
+ ∑𝑗=1
𝑦𝑖𝑗 ln(𝜇𝑖 𝜙𝑖 ) − ∑𝑗=1
(𝑦𝑖𝑗 + 𝜙 ) ln(1 + 𝜇𝑖 𝜙𝑖 )
𝑖

Differentiating with respect to 𝜇𝑖 and equating to zero, we get
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(7.5)

1
𝑖
𝑖
∑𝑁
∑𝑁
𝑗=1 (𝑦𝑖𝑗 + 𝜙 ) 𝜙𝑖
𝜕𝑙
𝑗=1 𝑦𝑖𝑗
𝑖
=
−
=0
(1 + 𝜇𝑖 𝜙𝑖 )
𝜕𝜇𝑖
𝜇𝑖
𝑁

⇒ 𝜇̂ 𝑖 =

𝑖 𝑦
∑𝑗=1
𝑖𝑗

(7.6)

𝑁𝑖

Differentiating with respect to 𝜙𝑖 and equating to zero, we get
1
1
1
𝑁𝑖
𝑁𝑖
𝑁𝑖
𝜕 ∑𝑗=1
ln 𝛤 (𝑦𝑖𝑗 + 𝜙 ) 𝜕 ∑𝑗=1
ln 𝛤 (𝜙 ) ∑𝑁𝑖 𝑦𝑖𝑗 ∑𝑗=1
(𝑦𝑖𝑗 + 𝜙 ) 𝜇𝑖
𝜕𝑙
𝑗=1
𝑖
𝑖
𝑖
=
−
+
−
(1 + 𝜇𝑖 𝜙𝑖 )
𝜕𝜙𝑖
𝜕𝜙𝑖
𝜕𝜙𝑖
𝜙𝑖
+

𝑁𝑖
ln(1 + 𝜇𝑖 𝜙𝑖 )
𝜙𝑖2

𝑁

Putting 𝜇̂ 𝑖 =

𝑖 𝑦
∑𝑗=1
𝑖𝑗

𝑁𝑖

in the above equation, we get
1
𝛤 (𝑦𝑖𝑗 + 𝜙 )
𝑖
)
1
𝑖
𝛤( )
∑𝑁
𝜙𝑖
𝑁𝑖
𝑗=1 𝑦𝑖𝑗
+ 2 ln (1 + 𝜙𝑖
)=0
𝜕𝜙𝑖
𝑁𝑖
𝜙𝑖

𝑁𝑖
𝜕 ∑𝑗=1
ln (

𝜕𝑙
=
𝜕𝜙𝑖

Further simplification leads to

𝜕𝑙
𝜕𝜙𝑖

1

= 𝜙2 {𝑁𝑖 ln (1 + 𝜙𝑖
𝑖

𝑁

𝑖 𝑦
∑𝑗=1
𝑖𝑗

𝑁𝑖

𝑁

𝑦 −1

𝑖𝑗
𝑖
∑𝑚=0
) − ∑𝑗=1

1
(𝑚+

}=0

1
)
𝜙𝑖

(7.7)

Since, the above equation is not in closed from, therefore, we have used
Newton’s method to estimate the dispersion parameter 𝜙. The second derivative
of log-likelihood function with respect to 𝜙𝑖 is given by
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𝜕2 𝑙
𝜕𝜙𝑖2

1
𝜙𝑖4

=−

2𝑁𝑖
𝜙𝑖3

𝑁

ln (1 + 𝜙𝑖

𝑦 −1

𝑖
∑𝑁
∑ 𝑗
𝑗=1 𝑚=0

𝑖 𝑦
∑𝑗=1
𝑖𝑗

𝑁𝑖

𝑁

)+

𝑖 𝑦
∑𝑗=1
𝑖𝑗

2

𝑁
3
∑ 𝑖 𝑦𝑗 𝜙𝑖
𝑗=1
)
𝜙𝑖2 (1+𝜙𝑖
𝑁𝑖

𝑦 −1

𝑖
∑𝑁
∑ 𝑖𝑗
𝑗=1 𝑚=0

1
(𝑚+

1
)
𝜙𝑖

−

1
(𝑚+

(7.8)

2
1
)
𝜙𝑖

Estimation of parameters with scaling factor: Let 𝑌𝑖𝑗 be a NB random variable
with mean 𝜇𝑖 and dispersion parameter 𝜙𝑖 , i.e., 𝑌𝑖𝑗 ~𝑁𝐵(𝑠𝑖𝑗 𝜇𝑖 , 𝜙𝑖 ), then its
probability mass function is given by

𝑝(𝑌𝑖𝑗 = 𝑦𝑖𝑗 ) =

𝛤(𝑦𝑖𝑗 +

1
)
𝜙𝑖

𝑦
(𝑠𝑖𝑗 𝜇𝑖 𝜙𝑖 ) 𝑖𝑗

1
1
𝑦𝑖𝑗 +
)𝛤(𝑦𝑖𝑗 +1)
𝜙𝑖
𝜙𝑖
(1+𝑠𝑖𝑗 𝜇𝑖 𝜙𝑖 )

𝛤(

; 𝑦𝑖𝑗 = 0, 1, 2, …

(7.9)

where, 𝑠𝑖𝑗 is the scaling factor to normalize raw read counts in the jth sample of
group 𝐺𝑖 . Then, the likelihood function 𝐿 and the log-likelihood function 𝑙 are
given below:

𝐿(𝜇𝑖 , 𝜙𝑖 |𝑦𝑖𝑗 ; 𝑗 = 1, 2, … , 𝑁𝑖 ) =

𝑖
∏𝑁
𝑗=1

𝛤(𝑦𝑖𝑗 +

1
)
𝜙𝑖

𝑦
(𝑠𝑖𝑗 𝜇𝑖 𝜙𝑖 ) 𝑖𝑗

(7.10)

1
1
𝑦𝑖𝑗 +
)𝛤(𝑦𝑖𝑗 +1)
𝜙𝑖
𝜙𝑖
(1+𝑠𝑖𝑗 𝜇𝑖 𝜙𝑖 )

𝛤(

𝑁𝑖

𝑁𝑖

𝑁𝑖

𝑗=1

𝑗=1

𝑗=1

1
1
𝑙(𝜇𝑖 , 𝜙𝑖 |𝑦𝑖𝑗 ; 𝑗 = 1, 2, … , 𝑁𝑖 ) = ∑ ln 𝛤 (𝑦𝑖𝑗 + ) − ∑ 𝛤 ( ) − ∑ ln 𝛤(𝑦𝑖𝑗 + 1)
𝜙𝑖
𝜙𝑖
𝑁

𝑁

1

𝑖
𝑖
+ ∑𝑗=1
𝑦𝑖𝑗 ln(𝑠𝑖𝑗 𝜇𝑖 𝜙𝑖 ) − ∑𝑗=1
(𝑦𝑖𝑗 + 𝜙 ) ln(1 + 𝑠𝑖𝑗 𝜇𝑖 𝜙𝑖 )
𝑖

Differentiating with respect to 𝜇𝑖 and equating to zero, we get
1
𝑁𝑖
𝑖
(𝑦𝑖𝑗 + 𝜙 ) 𝑠𝑖𝑗 𝜙𝑖
∑𝑁
𝑦
𝜕𝑙
𝑖𝑗
𝑗=1
𝑖
=
−∑
=0
𝜕𝜇𝑖
𝜇𝑖
(1 + 𝑠𝑖𝑗 𝜇𝑖 𝜙𝑖 )
𝑗=1
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(7.11)

𝑁

⇒ 𝜇̂ 𝑖 =

𝑖 𝑦
∑𝑗=1
𝑖𝑗

(7.12)

𝑁

𝑖 𝑠
∑𝑗=1
𝑖𝑗

Differentiating with respect to 𝜙𝑖 and equating to zero, we get
1
1
1
𝑁𝑖
𝑁𝑖
𝑁𝑖
𝜕 ∑𝑗=1
ln 𝛤 (𝑦𝑖𝑗 + 𝜙 ) 𝜕 ∑𝑗=1
ln 𝛤 (𝜙 ) ∑𝑁𝑖 𝑦𝑖𝑗
𝑦𝑖𝑗 + 𝜙
𝜕𝑙
𝑗=1
𝑖
𝑖
𝑖
=
−
+
− ∑(
)𝑠 𝜇
𝜕𝜙𝑖
𝜕𝜙𝑖
𝜕𝜙𝑖
𝜙𝑖
1 + 𝑠𝑖𝑗 𝜇𝑖 𝜙𝑖 𝑖𝑗 𝑖
𝑗=1

𝑁𝑖

+∑
𝑗=1

ln(1 + 𝑠𝑖𝑗 𝜇𝑖 𝜙𝑖 )
𝜙𝑖2
1
𝛤 (𝑦𝑖𝑗 + 𝜙 )

𝑁𝑖
𝜕 ∑𝑗=1
ln (

𝜕𝑙
⇒
=
𝜕𝜙𝑖

1
𝛤 (𝜙 )
𝑖

𝑖

)

𝑁𝑖

+∑

𝜕𝜙𝑖

𝑗=1

ln(1 + 𝑠𝑖𝑗 𝜇𝑖 𝜙𝑖 )
=0
𝜙𝑖2

𝑁

Putting 𝜇̂ 𝑖 =

𝜕𝑙
𝜕𝜙𝑖

=

𝑖 𝑦
∑𝑗=1
𝑖𝑗
𝑁

𝑖 𝑠
∑𝑗=1
𝑖𝑗

in the above equation, we obtain

𝑁

1

𝑁𝑖
{∑𝑗=1
ln (1
𝜙2

+

𝑖 𝑦
𝑠𝑖𝑗 ∑𝑗=1
𝑖𝑗
𝑁𝑖
∑𝑗=1
𝑠𝑖𝑗

𝑖

𝑦 −1

𝑁

𝑗
𝑖
∑𝑚=0
𝜙𝑖 ) − ∑𝑗=1

1
(𝑚+

}=0

(7.13)

1
)
𝜙𝑖

The second derivative with respect to 𝜙𝑖 obtained is given by

𝜕2 𝑙
𝜕𝜙𝑖2

=

𝑁

2

𝑁𝑖
− 𝜙3 ∑𝑗=1
ln (1

+

𝑖 𝑦
𝑠𝑖𝑗 ∑𝑗=1
𝑖𝑗
𝑁𝑖
∑𝑗=1
𝑠𝑖𝑗

𝑖

1

𝑁

𝑖
𝜙𝑖 ) + 𝜙2 ∑𝑗=1
𝑖

(
2
𝜙𝑖3

𝑦 −1

𝑖
∑𝑁
∑ 𝑗
𝑗=1 𝑚=0

1
1
(𝑚+ )
𝜙𝑖

1

𝑁

𝑦 −1

𝑗
𝑖
∑𝑚=0
− 𝜙4 ∑𝑗=1
𝑖

1
(𝑚+

2
1
)
𝜙𝑖
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𝑁
𝑠𝑖𝑗 ∑ 𝑖 𝑦𝑖𝑗
𝑗=1
𝑁
∑ 𝑖 𝑠𝑖𝑗
𝑗=1
𝑁
𝑠𝑖𝑗 ∑ 𝑖 𝑦𝑖𝑗
𝑗=1
1+ 𝑁
𝜙𝑖
∑ 𝑖 𝑠𝑖𝑗
𝑗=1

+
)
(7.14)

We used Newton’s method to estimate the dispersion parameter 𝜙𝑖 . If the
scaling factor is 1 for all the samples in the group, i.e., 𝑠𝑖𝑗 = 1, then the estimates
of parameters, 𝜇̂ 𝑖 and 𝜙̂𝑖 , obtained are same as those of the previous method of
estimating parameters without scaling factor. We developed R programs to
estimate the dispersion parameter for both cases, i.e., without scaling factor and
with scaling factor. For example, the estimated dispersion parameter for y = 14,
5, 12, 2, 9, 19 was found to be 0.2747. For same y and scaling factor, s = 1.1,
1.3, 0.9, 1.4, 1.2, 0.85, the value of estimated dispersion parameter is 0.2390.

Power and sample size calculation based on negative binomial distribution
The differential expression analysis in RNA-Seq data involves the calculation of
𝜇

fold change (FC = δ = 𝜇2 ) for each feature such as gene. Therefore, for testing
1

whether a feature is differentially expressed between two groups, we construct
the hypothesis setting as given below:
𝐻0 : 𝜇1 = 𝜇2 vs. 𝐻1 : 𝜇1 ≠ 𝜇2
This can be alternatively written as
𝐻0 : Δ = ∆0 vs. 𝐻1 : Δ ≠ ∆0
where Δ = 𝜇2 − 𝜇1 . If we have the null hypothesis that the population means are
equal, then ∆0 = 0.
The above settings of the hypothesis can be alternatively written as
𝐻0 : ln(𝛿) = ln(𝛿0 ) vs. 𝐻1 : ln(𝛿) ≠ ln(𝛿0 )
𝜇

where δ = 𝜇2. Here, 𝛿0 = 1 means the population means are equal in two groups.
1
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The methods based on Wald test and log transformed Wald test have been done
previously based on Poisson distribution and NB distribution [127, 128]. We used
Wald test, log transformed Wald test and score test based on generalized linear
model (GLiM) to estimate power and sample size calculation based on different
constraints. These methods are discussed below.
1. Power and sample size calculation using Wald test based on negative
binomial distribution
A. Method using Wald test statistic:
𝑁

𝑁

𝑖
𝑖
Given 𝑠𝑖 = ∑𝑗=1
𝑠𝑖𝑗 and 𝑌𝑖 = ∑𝑗=1
𝑦𝑖𝑗 for 𝑖 = 1, 2, the estimate of Wald test statistic

(Wald 1943) [129] has been derived below. The statistical inference is based on
the quantity
𝑇 = 𝜇̂ 2 − 𝜇̂ 1 =

𝑌2 𝑌1
−
𝑠2 𝑠1

The variance of 𝑇 is given by
𝜎𝑇2

𝜇2 𝜇1 𝜇22 𝜙2 𝜇12 𝜙1
= 𝑣𝑎𝑟(𝑇) =
+ +
+
𝑠2 𝑠1
𝑁2
𝑁1

The estimate of 𝜎𝑇2 (standard error under 𝐻1 ) is given by
𝑆𝑇2 =

𝜇̂ 2 𝜇̂ 1 𝜇̂ 22 𝜙̂2 𝜇̂ 12 𝜙̂1 𝑌2 𝑌1 𝑌22 𝜙̂2 𝑌12 𝜙̂1
+ +
+
= 2+ 2+ 2 + 2
𝑠2 𝑠1
𝑁2
𝑁1
𝑠2 𝑠1 𝑠2 𝑁2 𝑠1 𝑁1

𝑠

Let 𝑤 = 𝑠2 . The Wald test statistic with unequal sample sizes and dispersion
1

parameters is given by
𝑇

𝑧𝑤1 = 𝑆 =
𝑇

𝑌2 𝑌1
−
𝑠2 𝑠1
̂
̂
𝑌2 𝜙
𝑌2 𝜙
𝑌
𝑌
√ 22 + 21 + 22 2 + 21 1
𝑠2 𝑠1 𝑠2 𝑁2 𝑠1 𝑁1

=

𝑌2 −𝑤𝑌1
̂
̂
𝑌2 𝜙
𝑤2𝑌2
1 𝜙1
√𝑌2 +𝑤 2 𝑌1 + 2 2 +
𝑁2
𝑁1
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(7.15)

We reject null hypothesis when |𝑧𝑤1 | > 𝑧1−𝛼/2 . The power of the two-sided test is
given by
Pr[|𝑧𝑤1 | > 𝑧𝛼⁄2 |𝐻1 𝑖𝑠 𝑡𝑟𝑢𝑒] = 1 − 𝛽
Pr[𝑧𝑤1 > 𝑧𝛼⁄2 |𝐻1 𝑖𝑠 𝑡𝑟𝑢𝑒] + Pr[𝑧𝑤1 < 𝑧−𝛼⁄2 |𝐻1 𝑖𝑠 𝑡𝑟𝑢𝑒] = 1 − 𝛽
1 − Φ [𝑧𝛼⁄2 −

∆0 − ∆
∆0 − ∆
] + Φ [−𝑧𝛼⁄2 −
]=1−𝛽
𝑆𝑇
𝑆𝑇

1 − Φ [𝑧𝛼⁄2 +

∆ − ∆0
∆ − ∆0
] + Φ [−𝑧𝛼⁄2 +
]=1−𝛽
𝑆𝑇
𝑆𝑇

Alternatively, it can be written as
1 − Φ [𝑧𝛼⁄2 +
The term Φ [−𝑧𝛼⁄2 +

∆0 − ∆
∆0 − ∆
] + Φ [−𝑧𝛼⁄2 +
]=1−𝛽
𝑆𝑇
𝑆𝑇

∆0 −∆
𝑆𝑇

] has very little contribution to the power. Therefore, we

can ignore this term.
∆0 − ∆
]=𝛽
𝑆𝑇

Φ [−𝑧𝛼⁄2 +
−𝑧𝛼⁄2 +

∆0 − ∆
= 𝑧𝛽
𝑆𝑇

∆0 − ∆ 2
2
(
) = (𝑧𝛼⁄2 + 𝑧𝛽 )
𝑆𝑇
2

(∆0 − ∆)2 = (𝑧𝛼⁄2 + 𝑧𝛽 ) 𝑆𝑇2
2 𝜇
̂

̂
𝜇

(∆0 − ∆)2 = (𝑧𝛼⁄2 + 𝑧𝛽 ) ( 2 + 1 +
𝑠
𝑠
2

1

̂2
̂ 22 𝜙
𝜇
𝑁2

+

̂1
̂ 12 𝜙
𝜇
𝑁1

)

(7.16)

(B) Method using logarithmic transformation of Wald test statistic:
The logarithmic transformation is usually applied for skewness correction and
variance stabilization. The estimate of log transformed Wald test statistic [129] is
based on the quantity
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𝑈 = ln (
𝑌1
𝑠1

and

𝜇22 𝜙2
𝑁2

𝑌2
𝑠2

𝜇̂ 2
𝑌2
𝑌1
) = ln(𝜇̂ 2 ) − ln(𝜇̂ 1 ) = ln ( ) − ln ( )
𝜇̂ 1
𝑠2
𝑠1
𝜇12 𝜙1

𝜇

have asymptotic normal distributions, 𝑁 (𝜇1 , 𝑠 1 +

𝑁1

1

𝜇

) and 𝑁 (𝜇2 , 𝑠 2 +
2

𝑌

𝑌

), respectively. Therefore, by using Delta method, ln (𝑠1 ) and ln (𝑠2 ) have
1

respectively
𝑁 (ln(𝜇2 ) , 𝑠

asymptotic

1

normal

2

𝑁 (ln(𝜇1 ) , 𝑠

distributions,

1

1 𝜇1

𝜙

+ 𝑁1 )
1

and

𝜙

2 𝜇2

+ 𝑁2 ). The variance of 𝑈 is given by
2

𝜎𝑈2 = 𝑣𝑎𝑟(𝑈) =

1
1
𝜙2 𝜙1
+
+
+
𝑠2 𝜇2 𝑠1 𝜇1 𝑁2 𝑁1

The estimate of 𝜎𝑈2 (standard error under 𝐻1 ) is given by
𝑆𝑈2 =

1
1
𝜙̂2 𝜙̂1
1
1 𝜙̂2 𝜙̂1
+
+
+
= + +
+
𝑠2 𝜇̂ 2 𝑠1 𝜇̂ 1 𝑁2 𝑁1 𝑌2 𝑌1 𝑁2 𝑁1

Then, the log transformed Wald test with unequal sample sizes and dispersion
parameters is given by
𝑈

𝑧𝑤2 = 𝑆 =
𝑈

𝑌
ln( 2 )−ln(𝑤)

𝑌1
̂
̂
1
1 𝜙
𝜙
√ + + 2+ 1
𝑌2 𝑌1 𝑁2 𝑁1

(7.17)

We reject null hypothesis when |𝑧𝑤2 | > 𝑧1−𝛼/2 . The power of the two-sided test is
given by 1 − 𝛽 = Pr[|𝑧𝑤2 | > 𝑧𝛼⁄2 |𝐻1 𝑖𝑠 𝑡𝑟𝑢𝑒].
2

[ln(𝛿0 ) − ln(𝛿)]2 = (𝑧𝛼⁄2 + 𝑧𝛽 ) (
𝑠

1

̂2
2𝜇

+𝑠

1

̂1
1𝜇

̂
𝜙

̂
𝜙

+ 𝑁2 + 𝑁1 )
2

1

(7.18)

The above equation can be used to estimate power for the different input
parameters.

For

example,

if

𝜇1 = 𝜇2 = 20, 𝜙1 = 𝜙2 = 0.4, 𝑠1 = 18.5, 𝑠2 =

21.5, 𝑁1 = 𝑁2 = 20, then power achieved is 0.9043. To find the optimal allocation
of samples, the method may not be appropriate. However, if 𝑠𝑖𝑗 = 1, then 𝑠𝑖 = 𝑁𝑖 ,
and the above equation can be written as
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2

[ln(𝛿0 ) − ln(𝛿)]2 = (𝑧𝛼⁄2 + 𝑧𝛽 ) (
𝑁

1

̂2
2𝜇

+𝑁

̂
𝜙

1

̂1
1𝜇

̂
𝜙

+ 𝑁2 + 𝑁1 )
2

(7.19)

1

In this case, the above equation can be used to find optimal sample allocation
with sample size ratio fixed as well as optimal sample allocation for fixed cost to
get maximum power and minimum cost for a fixed power. The method using logtransformed Wald test will be equivalent to the method discussed in next section.
The methods using Wald test and log-transformed Wald test have been used for
testing the significance of single feature. These methods can be extended for
testing the significance of multiple features.
2. Sample size calculation using generalized linear model based on negative
binomial distribution
A. Sample size calculation for testing a single feature
The generalized linear model [130, 131] theory has been used to estimate
sample size using negative binomial distribution [132, 133]. The derivation of
sample size formula has been discussed previously in many works. For example,
score test has been used for power and sample size calculation in Hart et al.
[103]. The statistical properties of the test satisfy the following formula
1

[ln(𝛿)]2

= (𝑧𝛼/2 +

2 (𝜇 +𝜙1 )
𝑧𝛽 ) [ 1𝑁
1

+

(

1
+𝜙2 )
𝜇2

𝑁2

]

(7.20)

where ln(𝛿) is the desired log fold change; 𝜇1 and 𝜇2 are the average expected
count in groups 𝐺1 and 𝐺2 , respectively; 𝜙1 and 𝜙2 are the dispersion parameters
in groups 𝐺1 and 𝐺2 , respectively; 𝑁1 and 𝑁2 are the number of samples in
groups 𝐺1 and 𝐺2 , respectively; 𝑧𝑝 is the upper 100(p)th percentile of standard
normal distribution. Biological coefficient of variation is the square root of
dispersion parameter.
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We followed similar approaches as discussed in Chapter 6. We considered the
following two aspects for calculating sample size:
A1. Sample size allocation without cost constraint
𝑁

Let the sample size ratio (𝑁2 = 𝑟 ≥ 1) between two groups is fixed in advance.
1

Then, we use the starting sample size N1 that would be the smallest integer
satisfying the inequality
1

2

1

𝑁1𝑍 = [(𝜇 + 𝜙1 ) + (𝜇 + 𝜙2 )⁄𝑟] (𝑧𝛼/2 + 𝑧𝛽 ) ⁄(log ∆)2
1

(7.21)

2

Then, an incremental search can be done to obtain the target power. An example
of sample sizes and exact power obtained for different sample size ratio (1, 2 and
3) and different fold change (1.5, 2, 2.5 and 3) are shown in Table 7.1. We
assumed that the expected read counts (𝜇1 = 𝜇2 = 20) and dispersion parameter
(𝜙1 = 𝜙2 = 0.4) for both the groups are same. The value of 𝛼 chosen is 0.05 and
target power is 0.9.
Table 7.1. Sample sizes (𝑁1 , 𝑁2 ) and power computed with parameters 𝜇1 = 𝜇2 = 20,
𝜙1 = 𝜙2 = 0.4, 𝛼 = 0.05, 1 − 𝛽 = 0.90 for different combinations of r and Δ

Δ
1.5

2

2.5

3

r

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

1

58

58

0.9023

20

20

0.9045

12

12

0.9171

8

8

0.9058

2

44

88

0.9055

15

30

0.9045

9

18

0.9171

6

12

0.9058

3

39

117

0.9047

14

42

0.9175

8

24

0.9171

6

18

0.9350

A2. Sample allocation with maximum power for a fixed cost
A hypothetical example of cost model for case-control study has been illustrated.
Suppose there are 𝑁1 controls (group 1) and 𝑁2 cases (group 2). The overall cost
of the study comprises of the following components:
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(i) The sample procurement cost: 𝑐1 = 𝑎11 𝑁1 + 𝑎12 𝑁2
where 𝑎11 is the sample procurement cost per control sample and 𝑎12 is the
sample procurement cost per case sample.
(ii) Cost for library preparation and quality control: 𝑐2 = 𝑎2 (𝑁1 + 𝑁2 )
(Assuming equal costs for both cases and controls, 𝑎2 is the cost for library and
quality control per sample)
(iii) Sequencing cost: 𝑐3 = 𝑎3 (𝑁1 + 𝑁2 )/𝑚
(Given the alignment rate is m and average cost per million reads mapped to the
genes for one sample is 𝑎3 )
(iv) Cost of analysis: 𝑐4 = 𝑎4 (𝑁1 + 𝑁2 )

assuming 𝑎4 is the average cost per

sample for data analysis.
The total cost can be written in the form of 𝐶 = 𝐶1 𝑁1 + 𝐶2 𝑁2 , where 𝐶1 and 𝐶2 are
the average cost per sample in control and case, respectively. A hypothetical
example to show various costs involved in conducting RNA-Seq experiments is
shown below in Table 7.2.
Table 7.2. A hypothetical example of various costs involved in RNA-Seq experiment
Services
RNA isolation from tissue
Library preparation
Sample and Library QC
Sequencing cost
Bioinformatics Analysis
Cost per sample

Price per sample (in USD)
50
400
50
250
250
1000

We followed the same procedure as given in previous chapter (A2.1 of Chapter
1

1

6). We used √𝜇 + 𝜙1 and √𝜇 + 𝜙2 in place of 𝜎1 and 𝜎2 , respectively. We find
1

2

the optimal allocation giving the maximum power. A hypothetical example of
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sample sizes and power obtained for a fixed cost C (30000, 40000 and 50000)
with different input parameters is given in Table 7.3.
Table 7.3. Sample sizes (𝑁1 , 𝑁2 ) and the power obtained with parameters 𝜇1 = 𝜇2 = 20,
𝜙1 = 𝜙2 = 0.4, 𝛼 = 0.05, 𝐶1 = 1000, 𝐶2 = 1100 for different values of fixed cost C and
fold change
Δ
1.5

2

2.5

3

C

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

30000

14

14

0.3591

14

14

0.7805

14

14

0.9509

14

14

0.9912

40000

19

19

0.4614

19

19

0.8897

19

19

0.9878

19

19

0.9990

50000

23

24

0.5444

23

24

0.9431

23

24

0.9967

23

24

0.9999

B. Sample size calculation for testing multiple features
The sample size formula given in previous section is applicable to testing the
significance of single feature such as gene. However, the experimenters are
usually interested in testing the significance of multiple genes. The possible
outcomes for testing multiple hypotheses has been given in Table 6.5. The
sample size calculation method for testing single feature has been extended for
the multiple features. We have used a different method for controlling FDR [128,
134]. The marginal type I error over all the genes is given by
𝛼∗ = 𝑚

𝑚1 𝑞

0 (1−𝑞)

(7.22)

where, 𝑚1 is the expected number of significant features, 𝑚0 is the number of
true null hypotheses (unknown) and q is the FDR. We use 𝛼 ∗ in place of 𝛼 in the
sample size formula for multiple feature testing. Therefore, we need extra input
parameters, namely, FDR, number of features (m) and expected number of DE
features (m1). The above equation can be rewritten as
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𝛼∗ =

𝜋1 𝑞

(7.23)

𝜋0 (1−𝑞)

where 𝜋1 is the expected proportion of significant features, 𝜋0 is the proportion of
true null hypotheses.
B1. Sample size allocation without cost constraint
We have calculated sample sizes and exact power obtained with different sample
size ratio (1, 2 and 3) and fold change (1.5, 2, 2.5 and 3) for RNA-Seq
experiment (Table 7.4). We have assumed that there are 10000 features and the
expected number of significant features is 100. Further, we assumed that the
expected read counts (𝜇1 = 𝜇2 = 20) and dispersion parameter (𝜙1 = 𝜙2 = 0.4)
for both the groups are same. The value of 𝛼 and power are respectively 0.05
and 0.9. After controlling the FDR, we obtained the value of 𝛼 ∗ (𝛼 ∗ = 0.00053).
Table 7.4. Sample sizes (𝑁1 , 𝑁2 ) and power computed with parameters 𝑚1 = 100, 𝑚 =
10000, 𝜇1 = 𝜇2 = 20, 𝜙1 = 𝜙2 = 0.4, 𝛼 = 0.05, 𝑞 = 0.05, 1 − 𝛽 = 0.90

for

different

combinations of r and Δ
Δ
1.5

2

2.5

3

r

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

1

124

124

0.9023

43

43

0.9077

25

25

0.9139

17

17

0.9050

2

93

186

0.9023

32

64

0.9046

19

38

0.9188

13

26

0.9126

3

83

249

0.9040

29

87

0.9122

17

51

0.9212

12

36

0.9263

B2. Sample allocation with maximum power for a fixed cost
A hypothetical example of sample sizes and power obtained for a fixed cost C for
multiple features is given in Table 7.5.
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Table 7.5. Sample sizes (𝑁1 , 𝑁2 ) and the power obtained with parameters 𝑚1 =
100, 𝑚 = 10000, 𝜇1 = 𝜇2 = 20, 𝜙1 = 𝜙2 = 0.4, 𝛼 = 0.05, 𝑞 = 0.05, 𝐶1 = 1000, 𝐶2 = 1100
for different values of fixed cost C and fold change
Δ
1.5

2

2.5

3

C

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

𝑵𝟏

𝑵𝟐

Power

30000

14

14

0.031083

14

14

0.232548

14

14

0.559463

14

14

0.807493

40000

19

19

0.054654

19

19

0.389931

19

19

0.772098

19

19

0.943344

50000

23

24

0.081829

23

24

0.530618

23

24

0.888161

23

24

0.984153

We have developed shiny apps for calculating sample size and power based on
the above discussed methods. The apps will be useful to the experimenters in
the designing of their experiments.

A shiny app for sample size estimation based on Poisson-log normal
distribution
There are many tools and applications available for sample size calculations for
RNA-Seq experiments. One of the examples is Scotty [104],

that performs

sample size calculation and power analysis under cost constraint for RNA-Seq
experiments. In this method, the read counts are assumed to follow Poisson-Log
normal distribution. The original programs were written in MATLAB. However,
MATLAB is a proprietary software. Therefore, on a similar line, we have made an
improved user defined shiny application using R which is a freely available
software. We have implemented the method in R and C++ and, used shiny for
making the application. The program is more efficient in terms of computational
time. It will be easier for the experimenters to calculate the sample size required
for conducting the experiments according to the budget. The researchers can
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use the app for writing grants and conducting research projects, that will save
resources in terms of cost and time.
The experimenter can design the RNA-Seq experiment based on the pilot
experimental data. In this method, we assume the count data is modelled by
Poisson-log normal distribution. The data is normalized to the median value of all
samples. Then, the estimates of the sequencing depth parameters are obtained
by fitting Poisson log normal model. There are two sources of variation: biological
and technical (Non-Poisson and Poisson variance). It optimizes the read depth
and number of replicates. A screenshot of the app is shown below:

Figure 7.1. Shiny application to calculate sample size for RNA-Seq experiments using pilot data

The inputs to be provided by the user are as follows:
(i) Pilot data: The user must upload the data in a prescribed format as discussed
in the supplementary section. We have also provided some datasets that can be
used as pilot data. We encourage the user to provide the case-control data. If the
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data consists of either only control or only case, there must be at least two
replicates. After the data is uploaded, please specify the other inputs.
(ii) Additional information of data: The user has to upload the additional
information of the data containing the names of samples and group variables.
(iii) After the file is uploaded, the user has to select the name of variable for
comparison.
(iv) Cost per control sample
(v) Cost per case sample
(vi) Cost per million reads
(vii) Total budget: Please specify the budget constraint. We will calculate the
power achieved under the given budget constraint. The default value in “Inf”
meaning no budget constraint.
(viii) Desired fold change
(ix) The significance level (the default value is 0.05)
(x) Minimum number of genes to be detected
(xi) Maximum replication
(xii) Minimum reads per replication
(xiii) Maximum reads per replication
(xiv) Minimum percent unbiased genes
(xv) Power bias cut off
(xvi) Alignment rate
After specifying all the input parameters, we obtain the results showing the
experimental design with maximum power as well as cheapest experiment to
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achieve a desirable power. We obtain various exploratory plots such as
multidimensional scaling plot, rarefaction plot, power analysis curves, power and
cost plots for different experimental designs.
We used RNA-Seq data “HumanLiverBleckman” [104, 135] obtained from
http://scotty.genetics.utah.edu/scottyDatasets.php. This data has three control
(female) and three test (male) samples. Each sample was run in two technical
replicates. The count data of the technical replicates for each sample were
added. We used the following inputs for sample size and power calculation:
Table 7.6. The inputs provided for sample size and power calculation
Cost per control replicate

500

Cost per test replicate

600

Significance level

0.05

FC

2

Cost Per Million Reads

1000

Total budget

Inf

Minimum % detected

50

Max number of replicates

10

Minimum reads per replicate

10000000

Maximum reads per replicate

100000000

Minimum % unbiased genes

50

Power bias cutoff (%)

50

Alignment rate (%)

50

The estimates of dispersion parameters in control and test condition are 0.2454
and 0.2539 respectively. Total 90 experimental designs were tested. The least
expensive experiment is having 5 replicates with sequencing depth of 10 million
reads per replicate (power = 0.55). The most powerful experiment is having 10
replicates with sequencing depth of 100 million reads aligned per replicate
(power = 0.94).
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CHAPTER 8
DISCUSSION AND CONCLUSION

We investigated the design, analysis and sample size estimation methods for
high-throughput proteomics and RNA-Seq experiments. We developed various
approaches to analyze the kidney proteomics data and studied the heterogeneity
issues due to the technical steps in the presence of missing values. Furthermore,
we developed an application to standardize proteomics workflow for LC-MS data
that will aid in choosing the most appropriate technical methods. We studied the
impact of the technical variability on the study design of proteomics experiments.
We developed an interactive application for differential expression analysis of
label-free LC-MS proteomics data. The application can analyze the data at
protein as well as peptide level using various statistical tests. It can also handle
the missing values and adjust the effects of additional covariates. Furthermore,
we proposed sample size calculation methods under allocation and budget
constraints for detecting differentially expressed features in proteomics
experiments. We developed apps to compute sample sizes based on various
input parameters provided. In future, we will come up with more methods of
sample size calculation methods applicable to more than two class comparison
including additional covariates. We studied various methods of sample size
calculations in RNA-Seq experiments based on different models. We investigated

120

the estimation of dispersion parameter and sample size methods. We developed
different apps to compute sample sizes for conducting future RNA-Seq
experiments under different constraints. In future, we will develop the design,
analysis and sample size calculation methods for other biological studies such as
single-cell sequencing experiments.
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APPENDIX A
ACRONYMS USED

LC: Liquid chromatography
MS: Mass spectrometry
MCAR: Missing completely at random
MAR: Missing at random
MNAR: Missing not at random
MVs: Missing values
TSM: Tissue storage method
FFPE: Formalin-fixed paraffin embedded
FR: Frozen
TEM: Tissue extraction method
MAX: Protease MAX
TX: Triton X-100
SDS: Sodium dodecylsulfate
LCMD: Laser capture microdissection
ETD: Electron-transfer dissociation
CID: Collision-induced dissociation
cRAP: Common Repository of Adventitious Proteins
FDR: False discovery rate
CV: Coefficient of variation
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GLM: General linear model
ANOVA: Analysis of variance
ANCOVA: Analysis of covariance
SS: Sum of squares
SD: Standard deviation
PWST: Proteomics Workflow Standardization Tool
DE: Differential expression/ Differentially expressed
SSCP: Sample Size Calculator for Proteomics Experiment
SATP: Statistical Analysis Tool for Proteomics
NGS: Next-generation sequencing
ECM: Extracellular matrix
BH: Benjamini-Hochberg
BY: Bejamini-Yekutieli
MDS: Multidimensional scaling
SVD: Singular value decomposition
NB: Negative binomial
MME: Method of moments estimation
MLE: Maximum likelihood estimation
MQLE: Maximum quasi-likelihood estimation
CML: Conditional maximum likelihood
RPKM: Reads aligned per kilobase of exon per million reads mapped
FPKM: Fragments per kilobase of exon per million fragments mapped
TPM: Transcripts per kilobase million
FC: Fold change
GLiM: Generalized linear model
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